About   Help   FAQ
Due to maintenance, access to MGI may be intermittent 8:00 AM ET Wed, September 18.
Mammalian Phenotype Ontology Annotations
Query Results - Summary
70340 genotypes with 339972 annotations displayed of selected term and subterms
Searched Term: mammalian phenotype
Allelic Composition
(Genetic Background)
Annotated Term Reference
7a6ex/7a6ex
(involves: C3HeB/FeJ * C57BL/6J)
decreased forebrain size J:98216
embryonic lethality during organogenesis, complete penetrance J:98216
exencephaly J:98216
12aex/12aex
(involves: C3HeB/FeJ * C57BL/6J)
exencephaly J:98216
perinatal lethality, complete penetrance J:98216
31bex/31bex
(involves: C3HeB/FeJ * C57BL/6J)
decreased forebrain size J:98216
embryonic lethality during organogenesis, complete penetrance J:98216
exencephaly J:98216
38dlp/38dlp
(involves: C3HeB/FeJ * C57BL/6J)
abnormal lateral plate mesoderm morphology J:98216
abnormal somite development J:98216
embryonic growth arrest J:98216
embryonic lethality during organogenesis, complete penetrance J:98216
97c2/97c2
(involves: C3HeB/FeJ * C57BL/6J)
exencephaly J:98216
open neural tube J:98216
perinatal lethality, complete penetrance J:98216
917M/917M
(involves: C3H * C57BL/6J)
decreased compact bone thickness J:99483
917M/917M+
(C57BL/6-917M)
abnormal bone structure J:99483, J:132290
abnormal tibia morphology J:99483
decreased bone mineral content J:99483
decreased osteoblast proliferation J:99483
0610010K14Riktm1.1(KOMP)Vlcg/0610010K14Rik+
(C57BL/6N-0610010K14Riktm1.1(KOMP)Vlcg/MbpMmucd)
pale yolk sac J:211773
0610010K14Riktm1.1(KOMP)Vlcg/0610010K14Riktm1.1(KOMP)Vlcg
(C57BL/6N-0610010K14Riktm1.1(KOMP)Vlcg/MbpMmucd)
embryonic lethality prior to organogenesis J:211773
embryonic lethality prior to tooth bud stage J:211773
preweaning lethality, complete penetrance J:211773
1110017D15Rikem1Osb/1110017D15Rikem1Osb
(involves: C57BL/6 * DBA/2)
no abnormal phenotype detected J:234235
1110032A03Riktm1.1(KOMP)Vlcg/1110032A03Riktm1.1(KOMP)Vlcg
(C57BL/6N-1110032A03Riktm1.1(KOMP)Vlcg/MbpMmucd)
abnormal seminal vesicle morphology J:211773
decreased mean platelet volume J:211773
enlarged heart J:211773
1110059G10Riktm1a(KOMP)Wtsi/1110059G10Riktm1a(KOMP)Wtsi
(C57BL/6N-1110059G10Riktm1a(KOMP)Wtsi/Wtsi)
decreased circulating insulin level J:211773
vertebral transformation J:211773
1500009L16Rikem1(IMPC)Mbp/1500009L16Rikem1(IMPC)Mbp
(C57BL/6NCrl-1500009L16Rikem1(IMPC)Mbp/Mmucd)
decreased bone mineral content J:211773
decreased bone mineral density J:211773
decreased lean body mass J:211773
increased circulating alkaline phosphatase level J:211773
increased circulating aspartate transaminase level J:211773
increased circulating serum albumin level J:211773
1500011B03Riktm2(KOMP)Wtsi/1500011B03Riktm2(KOMP)Wtsi
(C57BL/6N-1500011B03Riktm2(KOMP)Wtsi/Wtsi)
increased circulating calcium level J:211773
1700001O22Rikem1(IMPC)J/1700001O22Rikem1(IMPC)J
(C57BL/6NJ-1700001O22Rikem1(IMPC)J/J)
decreased exploration in new environment J:211773
1700003F12Riktm1.1(KOMP)Vlcg/1700003F12Rik+
(C57BL/6N-1700003F12Riktm1.1(KOMP)Vlcg/MbpMmucd)
abnormal placenta size J:211773
1700003F12Riktm1.1(KOMP)Vlcg/1700003F12Riktm1.1(KOMP)Vlcg
(C57BL/6N-1700003F12Riktm1.1(KOMP)Vlcg/MbpMmucd)
abnormal embryo size J:211773
abnormal heart morphology J:211773
preweaning lethality, incomplete penetrance J:211773
1700007K13RikGt(OST3440)Lex/1700007K13RikGt(OST3440)Lex
(either: (involves: 129S5/SvEvBrd * C57BL/6J) or (involves: 129S5/SvEvBrd * C57BL/6J * FVB/N))
abnormal heart left ventricle morphology J:252050
abnormal heart morphology J:252050
abnormal kidney morphology J:252050
abnormal lateral plate mesoderm morphology J:252050
abnormal left-right axis patterning J:252050
abnormal liver lobule morphology J:252050
abnormal lung lobe morphology J:252050
abnormal lung position or orientation J:252050
abnormal mitral valve morphology J:252050
abnormal primitive node morphology J:252050
abnormal spleen morphology J:252050
dextrocardia J:252050
dilated heart atrium J:252050
heart hypoplasia J:252050
heterotaxia J:252050
left pulmonary isomerism J:252050
left sided inferior vena cava J:252050
lethality throughout fetal growth and development, incomplete penetrance J:252050
mesocardia J:252050
persistent truncus arteriosis J:252050
right pulmonary isomerism J:252050
right-sided stomach J:252050
situs inversus totalis J:252050
ventricular septal defect J:252050
1700007K13Riktm2b(EUCOMM)Wtsi/1700007K13Riktm2b(EUCOMM)Wtsi
(C57BL/6N-1700007K13Riktm2b(EUCOMM)Wtsi/Wtsi)
abnormal aortic valve cusp morphology J:239583
abnormal vertebral artery topology J:239583
absent segment of posterior cerebral artery J:239583
blood in lymph vessels J:239583
heterochrony J:239583
increased grip strength J:211773
muscular ventricular septal defect J:239583
no abnormal phenotype detected J:239583
retropleural edema J:239583
situs inversus totalis J:239583
1700008O03Riktm1a(KOMP)Wtsi/1700008O03Riktm1a(KOMP)Wtsi
(C57BL/6N-1700008O03Riktm1a(KOMP)Wtsi/Wtsi)
abnormal hair growth J:211773
1700012B09Riktm1.1(KOMP)Wtsi/1700012B09Riktm1.1(KOMP)Wtsi
(C57BL/6N-1700012B09Riktm1.1(KOMP)Wtsi/Bay)
decreased circulating serum albumin level J:211773
1700012B09Riktm1.1Gos/1700012B09Riktm1.1Gos
(involves: 129 * CAST * C57BL/6 * CD-1 * SJL)
no abnormal phenotype detected J:249115
1700015F17Rikem1Osb/1700015F17Rikem1Osb
(involves: C57BL/6 * DBA/2)
no abnormal phenotype detected J:234235
1700016K19Riktm1.1(KOMP)Vlcg/1700016K19Riktm1.1(KOMP)Vlcg
(B6N(Cg)-1700016K19Riktm1.1(KOMP)Vlcg/J)
abnormal behavior J:211773
abnormal behavioral response to light J:211773
hyperactivity J:211773
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(C.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan)
abnormal CD8-positive, alpha-beta T cell differentiation J:93488
abnormal T cell activation J:93488
decreased CD8-positive, alpha-beta T cell number J:93488
decreased cytotoxic T cell cytolysis J:93488
decreased dendritic cell number J:93488
increased neutrophil cell number J:194800
premature death J:93488
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(B6.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan/J)
abnormal NK cell physiology J:96123
abnormal NK T cell physiology J:96123
decreased circulating interferon-gamma level J:96123
decreased circulating interleukin-12 level J:96123
decreased dendritic cell number J:100867, J:113232, J:96123
decreased interferon-gamma secretion J:96123
decreased interleukin-4 secretion J:96123
decreased interleukin-12b secretion J:125611
immune system phenotype J:113232, J:122114, J:96123
impaired natural killer cell mediated cytotoxicity J:125611
increased sensitivity to induced morbidity/mortality J:113232
sepsis J:113232
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(C.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan/J)
abnormal NK cell physiology J:96123
decreased circulating interferon-gamma level J:96123
decreased circulating interleukin-12 level J:96123
decreased dendritic cell number J:96123
decreased interferon-gamma secretion J:96123
immune system phenotype J:96123
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(involves: C57BL/6 * FVB/N)
abnormal alveolar macrophage morphology J:137452
decreased dendritic cell number J:137452
decreased interferon-gamma secretion J:137452
increased susceptibility to viral infection J:137452
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(NOD.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan/Jdk)
abnormal professional antigen presenting cell physiology J:137009
cachexia J:137009
decreased dendritic cell number J:137009
decreased macrophage cell number J:137009
decreased NK T cell number J:137009
decreased susceptibility to autoimmune diabetes J:137009
endocrine/exocrine gland phenotype J:137009
increased interferon-gamma secretion J:137009
increased tumor necrosis factor secretion J:137009
insulitis J:137009
premature death J:137009
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(involves: FVB/N)
abnormal response to infection J:189122
decreased gamma-delta T cell number J:193548
decreased interleukin-17 secretion J:193548
decreased leukocyte cell number J:193548
decreased neutrophil cell number J:193548
decreased physiological sensitivity to xenobiotic J:193548
decreased susceptibility to bacterial infection J:210086
decreased T cell number J:193548
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(B6.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan)
abnormal circulating cytokine level J:194800
altered susceptibility to infection J:194800
decreased dendritic cell number J:194800
decreased neutrophil cell number J:194800
impaired neutrophil recruitment J:194800
increased monocyte cell number J:194800
increased neutrophil cell number J:194800
increased susceptibility to bacterial infection J:194800
1700019N19Rikem1Osb/1700019N19Rikem1Osb
(involves: C57BL/6 * DBA/2)
no abnormal phenotype detected J:234235
1700024P04Riktm1b(EUCOMM)Wtsi/1700024P04Riktm1b(EUCOMM)Wtsi
(C57BL/6N-1700024P04Riktm1b(EUCOMM)Wtsi/Wtsi)
decreased circulating free fatty acid level J:211773
male infertility J:211773
1700029I15Riktm1.1(KOMP)Vlcg/1700029I15Riktm1.1(KOMP)Vlcg
(C57BL/6N-1700029I15Riktm1.1(KOMP)Vlcg/Mmucd)
abnormal skin morphology J:211773
male infertility J:211773
1700034J05Riktm1b(KOMP)Wtsi/1700034J05Riktm1b(KOMP)Wtsi
(involves: 129 * BALB/c * C57BL/6N)
no abnormal phenotype detected J:234235
1700067K01Riktm2a(KOMP)Wtsi/1700067K01Rik+
(C57BL/6N-1700067K01Riktm2a(KOMP)Wtsi/Wtsi)
decreased blood urea nitrogen level J:211773
increased blood urea nitrogen level J:211773
1700067K01Riktm2a(KOMP)Wtsi/1700067K01Riktm2a(KOMP)Wtsi
(C57BL/6N-1700067K01Riktm2a(KOMP)Wtsi/Wtsi)
abnormal cervical rib J:239583
abnormal coronary artery morphology J:239583
abnormal forebrain morphology J:239583
abnormal lung morphology J:239583
abnormal Mullerian duct morphology J:239583
abnormal umbilical artery morphology J:239583
abnormal umbilical vein topology J:239583
abnormal vertebral artery topology J:239583
abnormal vitelline vein topology J:239583
absent ductus venosus valve J:239583
absent intrahepatic inferior vena cava segment J:239583
absent segment of posterior cerebral artery J:239583
arteriovenous malformation J:239583
bifid ureter J:239583
blood in lymph vessels J:239583
dual inferior vena cava J:239583
ductus venosus stenosis J:239583
fusion of vertebral arches J:239583
hepatic portal vein stenosis J:239583
preweaning lethality, complete penetrance J:211773
umbilical vein stenosis J:239583
1700086L19Riktm1b(EUCOMM)Wtsi/1700086L19Riktm1b(EUCOMM)Wtsi
(C57BL/6N-1700086L19Riktm1b(EUCOMM)Wtsi/Bay)
abnormal behavior J:211773
decreased bone mineral density J:211773
decreased lean body mass J:211773
decreased total body fat amount J:211773
hyperactivity J:211773
1700093K21Rikb2b3025Clo/1700093K21Rikb2b3025Clo
(C57BL/6J-1700093K21Rikb2b3025Clo)
abdominal situs ambiguus J:175213
abnormal inferior vena cava morphology J:175213
abnormal thoracic vertebrae morphology J:175213
dextrocardia J:175213
heterotaxia J:175213
right-sided stomach J:175213
1700093K21Riktm1Osb/1700093K21Riktm1Osb
(involves: C57BL/6NSlc)
no abnormal phenotype detected J:234235
1700125H20Riktm1b(EUCOMM)Wtsi/1700125H20Riktm1b(EUCOMM)Wtsi
(involves: 129 * BALB/c * C57BL/6N)
no abnormal phenotype detected J:234235
2010300C02Riktm1b(KOMP)Wtsi/2010300C02Riktm1b(KOMP)Wtsi
(C57BL/6N-2010300C02Riktm1b(KOMP)Wtsi/Wtsi)
decreased circulating cholesterol level J:211773
decreased food intake J:211773
decreased leukocyte cell number J:211773
improved glucose tolerance J:211773
increased leukocyte cell number J:211773
2210010C04Riktm1.1Satom/2210010C04Rik+
(B6(FVB)-2210010C04Riktm1.1Satom)
abnormal pancreas morphology J:267764
acute pancreas inflammation J:267764
chronic pancreas inflammation J:267764
decreased circulating amylase level J:267764
decreased pancreas weight J:267764
decreased pancreatic acinar cell number J:267764
enlarged pancreatic islets J:267764
homeostasis/metabolism phenotype J:267764
increased pancreas weight J:267764
pancreas atrophy J:267764
small pancreas J:267764
2210010C04Riktm1.1Satom/2210010C04Riktm1.1Satom
(B6(FVB)-2210010C04Riktm1.1Satom)
decreased body size J:267764
premature death J:267764
2210010C04Riktm1b(KOMP)Wtsi/2210010C04Riktm1b(KOMP)Wtsi
(C57BL/6N-2210010C04Riktm1b(KOMP)Wtsi/Bay)
abnormal retinal vasculature morphology J:211773
decreased circulating phosphate level J:211773
2210010C04Riktm2.1Satom/2210010C04Rik+
(involves: C57BL/6 * FVB/N)
endocrine/exocrine gland phenotype J:267764
2210408I21Riktm1b(EUCOMM)Wtsi/2210408I21Riktm1b(EUCOMM)Wtsi
(C57BL/6N-2210408I21Riktm1b(EUCOMM)Wtsi/Tcp)
abnormal kidney morphology J:211773
decreased bone mineral density J:211773
decreased lean body mass J:211773
hydrometra J:211773
impaired glucose tolerance J:211773
increased total body fat amount J:211773
small superior vagus ganglion J:211773
2300002M23Riktm1Lex/2300002M23Riktm1Lex
(B6;129S5-2300002M23Riktm1Lex/Mmucd)
decreased body weight J:171883
decreased total body fat amount J:171883
2310022B05Riktm1a(EUCOMM)Hmgu/2310022B05Riktm1a(EUCOMM)Hmgu
(C57BL/6N-2310022B05Riktm1a(EUCOMM)Hmgu/H)
increased B cell number J:165965
increased grip strength J:165965
increased leukocyte cell number J:165965
2310039L15RikTg(Prnp-SNCA*A53T)23Mkle/0
(involves: C3H/HeJ * C57BL/6J)
abnormal motor capabilities/coordination/movement J:77344
abnormal nervous system morphology J:77344
abnormal neuron morphology J:77344
abnormal spinal cord morphology J:77344
astrocytosis J:77344
ataxia J:77344
bradykinesia J:77344
dystonia J:77344
impaired righting response J:77344
neurodegeneration J:77344
neuronal intranuclear inclusions J:77344
paralysis J:77344
premature death J:77344
2510002D24Riktm1.1(KOMP)Vlcg/2510002D24Riktm1.1(KOMP)Vlcg
(C57BL/6N-2510002D24Riktm1.1(KOMP)Vlcg/MbpMmucd)
decreased startle reflex J:211773
2510002D24Riktm1.1(KOMP)Vlcg/2510002D24Riktm1.1(KOMP)Vlcg
(C57BL/6-2510002D24Riktm1.1(KOMP)Vlcg)
no abnormal phenotype detected J:260409
2610005L07RikGt(ROSA)73Sor/2610005L07RikGt(ROSA)73Sor
(involves: 129S4/SvJaeSor)
abnormal frontal bone morphology J:117491
abnormal neurocranium morphology J:117491
abnormal skeleton morphology J:117491
abnormal sternum morphology J:117491
asymmetric sternocostal joints J:117491
broad snout J:117491
increased fibroblast cell migration J:117491
prenatal lethality, incomplete penetrance J:117491
short maxilla J:117491
short nasal bone J:117491
short premaxilla J:117491
short snout J:117491
2610005L07RikGt(ROSA)73Sor/2610005L07RikGt(ROSA)73Sor
Pdgfratm1Sor/Pdgfra+

(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
abnormal ovary morphology J:142042
abnormal vascular smooth muscle morphology J:142042
anovulation J:142042
decreased circulating estradiol level J:142042
decreased corpora lutea number J:142042
decreased secondary ovarian follicle number J:142042
decreased theca cell number J:142042
female infertility J:142042
small ovary J:142042
uterus hypoplasia J:142042
2610005L07RikGt(ROSA)73Sor/2610005L07RikGt(ROSA)73Sor
Pdgfratm2Sor/Pdgfra+

(involves: 129S4/SvJaeSor)
abnormal frontal bone morphology J:117491
abnormal skeleton morphology J:117491
broad snout J:117491
short maxilla J:117491
short nasal bone J:117491
short premaxilla J:117491
short snout J:117491
2610301B20Rikem1Jyang/2610301B20Rikem1Jyang
(involves: C57BL/6 * CBA)
decreased a wave amplitude J:259133
decreased b wave amplitude J:259133
growth/size/body region phenotype J:259133
increased a wave implicit time J:259133
2610301B20Rikem2Jyang/2610301B20Rikem2Jyang
(involves: C57BL/6 * CBA)
decreased a wave amplitude J:259133
decreased b wave amplitude J:259133
growth/size/body region phenotype J:259133
increased a wave implicit time J:259133
2610301B20Rikem3Jyang/2610301B20Rikem3Jyang
(involves: C57BL/6 * CBA)
abnormal cone electrophysiology J:259133
abnormal electroretinogram waveform feature J:259133
abnormal photoreceptor outer segment morphology J:259133
abnormal retinal photoreceptor morphology J:259133
abnormal rod electrophysiology J:259133
decreased a wave amplitude J:259133
decreased b wave amplitude J:259133
decreased retinal photoreceptor cell number J:259133
decreased total retina thickness J:259133
growth/size/body region phenotype J:259133
increased a wave implicit time J:259133
increased b wave implicit time J:259133
limbs/digits/tail phenotype J:259133
renal/urinary system phenotype J:259133
retinal degeneration J:259133
short photoreceptor outer segment J:259133
thin retinal outer nuclear layer J:259133
2610318N02Riktm1b(EUCOMM)Wtsi/2610318N02Riktm1b(EUCOMM)Wtsi
(C57BL/6N-2610318N02Riktm1b(EUCOMM)Wtsi/Wtsi)
decreased circulating creatinine level J:211773
2610528A11Riktm1Lex/2610528A11Riktm1Lex
(B6;129S5-2610528A11Riktm1Lex/Mmucd)
increased IgG2a level J:171883
2700049A03Riktm1.1Arte/2700049A03Riktm1.1Arte
Tg(Prrx1-cre)1Cjt/0

(involves: C57BL/6J * C57BL/6NTac * SJL/J)
abnormal carpal bone morphology J:175541
abnormal cell morphology J:175541
abnormal digit development J:175541
abnormal digit morphology J:175541
abnormal embryonic autopod plate morphology J:175541
abnormal endochondral bone ossification J:175541
abnormal limb mesenchyme morphology J:175541
abnormal long bone epiphyseal plate morphology J:175541
abnormal skeleton development J:175541
brachydactyly J:175541
decreased fibroblast cell migration J:175541
decreased length of long bones J:175541
polydactyly J:175541
polysyndactyly J:175541
short femur J:175541
short fibula J:175541
short humerus J:175541
short limbs J:175541
short radius J:175541
short scapula J:175541
short tibia J:175541
short ulna J:175541
2700049A03Riktm1.2Arte/2700049A03Riktm1.2Arte
(either: (involves: C57BL/6NTac) or (involves: C57BL/6NTac * CD-1))
abnormal centrosome morphology J:175541
abnormal direction of heart looping J:175541
abnormal lateral nasal prominence morphology J:175541
abnormal left-right axis patterning J:175541
abnormal medial nasal prominence morphology J:175541
abnormal neural tube morphology J:175541
absent embryonic cilia J:175541
embryonic growth arrest J:175541
embryonic lethality during organogenesis, complete penetrance J:175541
hemorrhage J:175541
narrow head J:175541
pericardial edema J:175541
2700049A03Riktm1Blnw/2700049A03Riktm1Blnw
(Not Specified)
abnormal cell morphology J:220629
2700054A10Rikem2(IMPC)Mbp/2700054A10Rikem2(IMPC)Mbp
(C57BL/6NCrl-2700054A10Rikem2(IMPC)Mbp/Mmucd)
abnormal eye morphology J:211773
abnormal seminal vesicle morphology J:211773
anophthalmia J:211773
hydrometra J:211773
small superior vagus ganglion J:211773
2700097O09Riktm1.1(KOMP)Vlcg/2700097O09Riktm1.1(KOMP)Vlcg
(C57BL/6N-2700097O09Riktm1.1(KOMP)Vlcg/MbpMmucd)
limb grasping J:211773
2810408A11Riktm1a(EUCOMM)Wtsi/2810408A11Riktm1a(EUCOMM)Wtsi
(C57BL/6N-2810408A11Riktm1a(EUCOMM)Wtsi/H)
abnormal bone mineralization J:165965
abnormal bone structure J:165965
decreased NK cell number J:165965
increased body weight J:165965
increased CD4-positive, alpha beta T cell number J:165965
increased heart weight J:165965
increased NK cell number J:165965
limb grasping J:165965
2900026A02Riktm1a(EUCOMM)Hmgu/2900026A02Riktm1a(EUCOMM)Hmgu
(C57BL/6N-2900026A02Riktm1a(EUCOMM)Hmgu/Ics)
abnormal eye morphology J:165965
abnormal retina morphology J:165965
2900092C05Rikem1Osb/2900092C05Rikem1Osb
(involves: C57BL/6 * DBA/2)
no abnormal phenotype detected J:234235
3830406C13Riktm1b(KOMP)Wtsi/3830406C13Riktm1b(KOMP)Wtsi
(C57BL/6N-3830406C13Riktm1b(KOMP)Wtsi/Wtsi)
decreased bone mineral content J:211773
decreased lean body mass J:211773
decreased total body fat amount J:211773
increased bone mineral content J:211773
increased lean body mass J:211773
increased red blood cell distribution width J:211773
increased total body fat amount J:211773
3830417A13Riktm1a(KOMP)Wtsi/3830417A13Riktm1a(KOMP)Wtsi
(C57BL/6N-3830417A13Riktm1a(KOMP)Wtsi/Wtsi)
decreased caudal vertebrae number J:211773
4833420G17Rikem1(IMPC)Mbp/4833420G17Rikem1(IMPC)Mbp
(C57BL/6NCrl-4833420G17Rikem1(IMPC)Mbp/Mmucd)
decreased body length J:211773
4921536K21Riktm1a(KOMP)Wtsi/4921536K21Riktm1a(KOMP)Wtsi
(C57BL/6N-4921536K21Riktm1a(KOMP)Wtsi/Wtsi)
increased grip strength J:211773
4930404H24Riktm1a(KOMP)Wtsi/4930404H24Riktm1a(KOMP)Wtsi
(C57BL/6N-4930404H24Riktm1a(KOMP)Wtsi/Wtsi)
decreased bone mineral content J:211773
decreased circulating free fatty acid level J:211773
decreased lean body mass J:211773
decreased total body fat amount J:211773
increased bone mineral content J:211773
increased lean body mass J:211773
increased mean platelet volume J:211773
increased total body fat amount J:211773
4930412L05Riktm1.1Pton/4930412L05Riktm1.1Pton
(B6.Cg-4930412L05Riktm1.1Pton)
hepatic steatosis J:233670
increased liver cholesterol level J:233670
4930447C04Rikem1Amp/4930447C04Rikem1Amp
(involves: C57BL/6J * CBA/J)
abnormal chiasmata formation J:238491
abnormal chromosomal synapsis J:238491
abnormal male meiosis J:238491
abnormal meiosis J:238491
abnormal oogenesis J:238491
abnormal ovarian follicle number J:238491
abnormal ovary morphology J:238491
abnormal seminiferous tubule morphology J:238491
abnormal X-Y chromosome synapsis during male meiosis J:238491
absent oocytes J:238491
arrest of male meiosis J:238491
azoospermia J:238491
female infertility J:238491
increased male germ cell apoptosis J:238491
male infertility J:238491
small testis J:238491
4930451I11Riktm1.1(KOMP)Wtsi/4930451I11Riktm1.1(KOMP)Wtsi
(C57BL/6N-4930451I11Riktm1.1(KOMP)Wtsi/Bay)
female infertility J:211773
male infertility J:211773
4930453N24Rikdin/4930453N24Rikdin
(B6C3Fe a/a-4930453N24Rikdin/J)
abnormal coat/hair pigmentation J:32738
abnormal dentin development J:32738
abnormal dentin morphology J:32738
abnormal incisor morphology J:32738
failure of tooth eruption J:32738
irregular coat pigmentation J:32738
malocclusion J:32738
postnatal growth retardation J:32738
premature death J:32738
small ears J:32738
4930522H14Rikem1Osb/4930522H14Rikem1Osb
(involves: C57BL/6 * DBA/2)
no abnormal phenotype detected J:234235
4930563E22Riktm1.1(KOMP)Vlcg/4930563E22Riktm1.1(KOMP)Vlcg
(B6N(Cg)-4930563E22Riktm1.1(KOMP)Vlcg/J)
abnormal bone structure J:211773
decreased bone mineral content J:211773
decreased fasting circulating glucose level J:211773
increased bone mineral content J:211773
4930590J08Riktm1a(EUCOMM)Wtsi/4930590J08Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4930590J08Riktm1a(EUCOMM)Wtsi/Wtsi)
male infertility J:211773
4930591A17Riktm1a(KOMP)Wtsi/4930591A17Riktm1a(KOMP)Wtsi
(C57BL/6N-4930591A17Riktm1a(KOMP)Wtsi/Wtsi)
increased bone mineral content J:211773
increased bone mineral density J:211773
increased lean body mass J:211773
increased red blood cell distribution width J:211773
4931406B18Rikem1Osb/4931406B18Rikem1Osb
(involves: C57BL/6 * DBA/2)
no abnormal phenotype detected J:234235
4931406P16Rikem1(IMPC)J/4931406P16Rikem1(IMPC)J
(C57BL/6NJ-4931406P16Rikem1(IMPC)J/J)
abnormal behavior J:211773
abnormal behavioral response to light J:211773
hyperactivity J:211773
4931429L15Riktm1a(EUCOMM)Wtsi/4931429L15Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4931429L15Riktm1a(EUCOMM)Wtsi/Wtsi)
increased caudal vertebrae number J:211773
4932414N04Riktm1a(KOMP)Wtsi/4932414N04Riktm1a(KOMP)Wtsi
(C57BL/6N-4932414N04Riktm1a(KOMP)Wtsi/Wtsi)
increased mature B cell number J:211773
4932431P20Rikem1(IMPC)Wtsi/4932431P20Rikem1(IMPC)Wtsi
(C57BL/6N-4932431P20Rikem1(IMPC)Wtsi/Wtsi)
decreased circulating magnesium level J:211773
increased circulating magnesium level J:211773
4932438A13Riktm1b(EUCOMM)Hmgu/4932438A13Rik+
(C57BL/6N-4932438A13Riktm1b(EUCOMM)Hmgu/Ieg)
abnormal lens morphology J:211773
4932438A13Riktm1b(EUCOMM)Hmgu/4932438A13Rik+
(B6N(Cg)-4932438A13Riktm1b(EUCOMM)Hmgu/J)
abnormal behavior J:211773
decreased circulating triglyceride level J:211773
increased circulating chloride level J:211773
4932438A13Riktm1b(EUCOMM)Hmgu/4932438A13Riktm1b(EUCOMM)Hmgu
(C57BL/6N-4932438A13Riktm1b(EUCOMM)Hmgu/Ieg)
preweaning lethality, complete penetrance J:211773
4932438A13Riktm1b(EUCOMM)Hmgu/4932438A13Riktm1b(EUCOMM)Hmgu
(B6N(Cg)-4932438A13Riktm1b(EUCOMM)Hmgu/J)
abnormal embryo size J:211773
embryonic growth retardation J:211773
hemorrhage J:211773
pallor J:211773
preweaning lethality, complete penetrance J:211773
4932438H23Riktm1a(EUCOMM)Wtsi/4932438H23Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4932438H23Riktm1a(EUCOMM)Wtsi/Wtsi)
increased circulating thyroxine level J:211773
4933402N03Riktm2a(KOMP)Wtsi/4933402N03Riktm2a(KOMP)Wtsi
(C57BL/6N-4933402N03Riktm2a(KOMP)Wtsi/Wtsi)
abnormal cranium morphology J:211773
abnormal hair growth J:211773
decreased circulating fructosamine level J:211773
4933417A18Rikem1Osb/4933417A18Rikem1Osb
(involves: C57BL/6 * DBA/2)
no abnormal phenotype detected J:234235
4933427D14Riktm1.1(KOMP)Vlcg/4933427D14Rik+
(B6N(Cg)-4933427D14Riktm1.1(KOMP)Vlcg/J)
abnormal embryo size J:211773
4933427D14Riktm1.1(KOMP)Vlcg/4933427D14Riktm1.1(KOMP)Vlcg
(B6N(Cg)-4933427D14Riktm1.1(KOMP)Vlcg/J)
embryonic lethality prior to organogenesis J:211773
preweaning lethality, complete penetrance J:211773
4933428G20Riktm1.1(KOMP)Vlcg/4933428G20Riktm1.1(KOMP)Vlcg
(C57BL/6N-4933428G20Riktm1.1(KOMP)Vlcg/MbpMmucd)
prolonged QRS complex duration J:211773
4933430I17Riktm1a(EUCOMM)Wtsi/4933430I17Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933430I17Riktm1a(EUCOMM)Wtsi/Ics)
abnormal pancreas morphology J:211773
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Rik+
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi)
decreased circulating cholesterol level J:211773
decreased circulating fructosamine level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating serum albumin level J:211773
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi)
abnormal aortic valve cusp morphology J:239583
abnormal atrioventricular cushion morphology J:239583
abnormal brain internal capsule morphology J:239583
abnormal cerebral cortex morphology J:239583
abnormal ductus venosus valve morphology J:239583
abnormal ductus venosus valve topology J:239583
abnormal dural venous sinus morphology J:239583
abnormal eye muscle morphology J:239583
abnormal forebrain morphology J:239583
abnormal heart atrium morphology J:239583
abnormal heart position or orientation J:239583
abnormal heart right atrium morphology J:239583
abnormal hindbrain morphology J:239583
abnormal hypoglossal nerve topology J:239583
abnormal inferior vena cava valve morphology J:239583
abnormal infrahyoid muscle connection J:239583
abnormal interatrial septum morphology J:239583
abnormal larynx morphology J:239583
abnormal lens morphology J:239583
abnormal Mullerian duct morphology J:239583
abnormal pectinate muscle morphology J:239583
abnormal pineal gland morphology J:239583
abnormal pulmonary valve cusp morphology J:239583
abnormal vertebral arch morphology J:239583
abnormal vertebral artery topology J:239583
abnormal vertebral body morphology J:239583
abnormal vitelline vein connection J:239583
abnormal Wolffian duct connection J:239583
absent costovertebral joint J:239583
absent ductus venosus valve J:239583
absent hypoglossal canal J:239583
absent hypoglossal nerve J:239583
absent lobe of thyroid gland J:239583
absent segment of posterior cerebral artery J:239583
absent vertebral arch J:239583
anal atresia J:239583
arteriovenous malformation J:239583
blood in lymph vessels J:239583
dorsal root ganglion hypoplasia J:239583
double ureter J:239583
embryo cyst J:239583
enlarged liver sinusoidal spaces J:239583
enlarged lymphatic vessel J:239583
fused dorsal root ganglion J:239583
fusion of vertebral arches J:239583
herniated liver J:239583
heterochrony J:239583
intestinal/bowel diverticulum J:239583
muscular ventricular septal defect J:239583
overriding aortic valve J:239583
perimembraneous ventricular septal defect J:239583
persistent trigeminal artery J:239583
preweaning lethality, complete penetrance J:211773
reduced sympathetic cervical ganglion size J:239583
retro-esophageal left subclavian artery J:239583
retroesophageal right subclavian artery J:239583
right aortic arch J:239583
small superior cervical ganglion J:239583
subcutaneous edema J:239583
thin hypoglossal nerve J:239583
urinary bladder hypoplasia J:239583
5330417C22Riktm1b(EUCOMM)Hmgu/5330417C22Rik+
(C57BL/6N-5330417C22Riktm1b(EUCOMM)Hmgu/Ics)
abnormal retinal blood vessel morphology J:211773
abnormal retinal vasculature morphology J:211773
abnormal vitreous body morphology J:211773
decreased lymphocyte cell number J:211773
increased circulating glucose level J:211773
increased neutrophil cell number J:211773
short tibia J:211773
5330417C22Riktm1b(EUCOMM)Hmgu/5330417C22Riktm1b(EUCOMM)Hmgu
(C57BL/6N-5330417C22Riktm1b(EUCOMM)Hmgu/Ics)
preweaning lethality, incomplete penetrance J:211773
5330417C22Riktm1Lex/5330417C22Riktm1Lex
(B6;129S5-5330417C22Riktm1Lex/Mmucd)
abnormal spermatogenesis J:171883
male infertility J:171883
oligozoospermia J:171883
teratozoospermia J:171883
5430431A17Rikem1Doca/5430431A17Rikem1Doca
(C57BL/6-5430431A17Rikem1Doca)
abnormal skeletal muscle fiber morphology J:266332
decreased heart left ventricle size J:266332
decreased heart right ventricle size J:266332
heart hyperplasia J:266332
increased heart weight J:266332
increased systemic arterial diastolic blood pressure J:266332
increased systemic arterial systolic blood pressure J:266332
premature death J:266332
thick ventricular wall J:266332
5830411N06Riktm1b(KOMP)Wtsi/5830411N06Riktm1b(KOMP)Wtsi
(C57BL/6N-Atm1Brd 5830411N06Riktm1b(KOMP)Wtsi/MbpMmucd)
abnormal epididymis morphology J:211773
enlarged epididymis J:211773
6030468B19Riktm1Lex/6030468B19Riktm1Lex
(B6;129S5-6030468B19Riktm1Lex/Mmucd)
no abnormal phenotype detected J:171883
9330182L06Riktm1a(KOMP)Wtsi/9330182L06Riktm1a(KOMP)Wtsi
(C57BL/6N-9330182L06Riktm1a(KOMP)Wtsi/Wtsi)
decreased leukocyte cell number J:211773
9430015G10Riktm1Lex/9430015G10Riktm1Lex
(B6;129S5-9430015G10Riktm1Lex/Mmucd)
decreased CD4-positive, alpha beta T cell number J:171883
increased B cell number J:171883
increased thermal nociceptive threshold J:171883
9630013A20Rikem1Qrlu/9630013A20Rikem1Qrlu
(Not Specified)
abnormal oligodendrocyte morphology J:256017
dysmyelination J:256017
nervous system phenotype J:256017
9930012K11Riktm2b(EUCOMM)Hmgu/9930012K11Riktm2b(EUCOMM)Hmgu
(C57BL/6N-9930012K11Riktm2b(EUCOMM)Hmgu/Bay)
decreased circulating alanine transaminase level J:211773
a/a
(involves: SM/J)
endocrine/exocrine gland phenotype J:19308
a/a
(Not Specified)
abnormal coat/hair pigmentation J:36414
darkened coat color J:36414
a/a
Bloc1s6pa/Bloc1s6pa

(involves: C57BL/6J)
abnormal retinal melanin granule morphology J:5346
a/a
Corintm1Bamo/Corintm1Bamo

(involves: 129X1/SvJ * C57BL/6 * FVB/N)
integument phenotype J:130426
a/a
DctSlt-lt/Dct+

(involves: C3H/HeJ)
diluted coat color J:27515
a/a
DctSlt-lt/DctSlt-lt

(involves: C3H/HeJ)
diluted coat color J:27515
a/a
Hps6ru-5J/Hps6ru-5J
Lystbg/Lystbg

(involves: C3H/Rl * C57BL/6J)
abnormal coat/hair pigmentation J:26546
abnormal eye pigmentation J:26546
decreased eye pigmentation J:26546
diluted coat color J:26546
a/a
Hps6ru/Hps6ru

(B6.Cg-Hps6ru)
abnormal coat/hair pigmentation J:6064
abnormal kidney physiology J:6422
abnormal lateral geniculate nucleus morphology J:6064
abnormal retinal ganglion cell morphology J:6064
decreased platelet ADP level J:7327
decreased platelet ATP level J:7327
decreased platelet dense granule number J:7327
decreased platelet serotonin level J:29748, J:7327
decreased susceptibility to atherosclerosis J:29748
increased bleeding time J:7327
a/a
Hps6ru/Hps6ru

(Not Specified)
abnormal choroid pigmentation J:81444
abnormal eye pigmentation J:13122, J:81444
abnormal iris pigmentation J:13122
decreased eye pigmentation J:13122
diluted coat color J:13122
hypopigmentation J:12970
a/a
Hps6ru/Hps6ru

(involves: C57BL/6J)
abnormal eye pigmentation J:5346
abnormal melanogenesis J:5346
abnormal melanosome morphology J:5346
a/a
Hps6ru/Hps6ru
Lystbg/Lystbg

(involves: C3H/Rl * C57BL/6J)
abnormal melanogenesis J:5346
abnormal melanosome morphology J:5346
abnormal retinal melanin granule morphology J:5346
a/a
In(11Trp53;11Wnt3)8Brd/+

(involves: 129S7/SvEvBrd * C57BL/6Brd * C57BL/6J)
abnormal tail pigmentation J:56548
a/a
KitW-2J/Kit+

(involves: C57BL/6J)
white spotting J:192797
a/a
Lystbg/Lystbg

(involves: C3H/Rl * C57BL/6J)
abnormal choroid melanin granule morphology J:5346
abnormal retinal melanin granule morphology J:5346
a/a
Lystbg/Lystbg
Oca2p-J/Oca2p-J

(involves: C3H/HeJ * C3H/Rl * C57BL/6J)
abnormal choroid melanin granule morphology J:5346
abnormal melanosome morphology J:5346
a/a
Lystbg/Lystbg
Tyrc/Tyrc

(involves: C3H/Rl * C57BL/6J)
abnormal choroid melanin granule morphology J:5346
abnormal melanogenesis J:5346
abnormal melanosome morphology J:5346
abnormal retinal melanin granule morphology J:5346
a/a
Lystbg/Lystbg
Tyrp1b/Tyrp1b

(involves: C3H/Rl * C57BL/6J)
abnormal choroid melanin granule morphology J:5346
abnormal retinal melanin granule morphology J:5346
a/a
Mc1re/Mc1re
Pomctm1Sora/Pomctm1Sora
Tg(MC1R)1Jkn/?

(involves: 129S6/SvEvTac * C57BL/6Ha)
abnormal hair follicle pheomelanosome pheomelanin content J:129904
yellow coat color J:129904
a/a
Mlphln/Mlphln

(involves: C57BL/J * C57BR)
abnormal choroid melanin granule morphology J:5346
abnormal hair follicle melanin granule distribution J:5346
a/a
Mlphln/Mlphln

(Not Specified)
abnormal coat/hair pigmentation J:12970
abnormal hair follicle melanocyte morphology J:12970
abnormal hair shaft melanin granule distribution J:12970
diluted coat color J:12970
a/a
Mlphln/Mlphln
Tyrp1b/Tyrp1b

(C57L/J)
abnormal coat/hair pigmentation J:5095
abnormal melanocyte morphology J:5095
diluted coat color J:5095
a/a
Mregdsu/Mregdsu
Hps6ru/Hps6ru

(involves: C57BL/6J)
diluted coat color J:29467
phenotypic reversion J:29467
a/a
Mssq1KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq3KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq4KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq5C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq6C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq6KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq7KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq8C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq9C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq10KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq11KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq12KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq13C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq13KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq14KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq15C57BL/6JJcl/Mssq15KK/TaJcl

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Mssq16KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
a/a
Myo5ad/Myo5a+
Oca2p/Oca2+
Tyrp1B-lt/Tyrp1+

(involves: C58 * CT/Ch)
diluted coat color J:13094
a/a
Myo5ad/Myo5ad

(involves: DBA/2J)
abnormal choroid melanin granule morphology J:5346
abnormal hair follicle melanin granule distribution J:5346
a/a
Myo5ad/Myo5ad

(Not Specified)
abnormal coat/hair pigmentation J:12958
abnormal eye pigmentation J:12958
abnormal hair shaft melanin granule distribution J:12958
abnormal hair shaft morphology J:12958
abnormal melanocyte morphology J:12970
diluted coat color J:12958
a/a
Oca2p-J/Oca2p-J

(involves: C3H/HeJ)
abnormal choroid melanin granule morphology J:5346
abnormal melanogenesis J:5346
abnormal melanosome morphology J:5346
a/a
Oca2p/Oca2p

(Not Specified)
abnormal coat/hair pigmentation J:78801, J:12958
abnormal hair follicle melanin granule distribution J:12958
abnormal hair follicle melanin granule morphology J:12958
abnormal hair follicle melanin granule shape J:12958
abnormal hair follicle melanocyte morphology J:78801
decreased ear pigmentation J:78801, J:36414
decreased eye pigmentation J:78801
decreased skin pigmentation J:36414
decreased tail pigmentation J:78801
a/a
Pax3Sp-1H/Pax3Sp-1H

(involves: 101/H * C3H/HeH * C57BL/6)
abnormal cerebral cortex morphology J:19818
abnormal lateral ventricle morphology J:19818
absent choroid plexus J:19818
absent olfactory bulb J:19818
exencephaly J:19818
incomplete rostral neuropore closure J:19818
a/a
Rab27aash/Rab27aash

(involves: C3H/HeSnJ * C57BL/6J)
decreased platelet serotonin level J:77395
hematopoietic system phenotype J:77395
increased bleeding time J:77395
a/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+

(involves: C57BL/6 * KK)
behavior/neurological phenotype J:168271
decreased body weight J:168271
decreased circulating glucose level J:168271
decreased gonadal fat pad weight J:168271
decreased liver weight J:168271
improved glucose tolerance J:168271
a/a
Tyrc-i/Tyrc-i

(involves: STOCK Tyrc-r)
abnormal coat/hair pigmentation J:83666
diluted coat color J:83666
a/a
Tyrc/Tyrc

(involves: C57BL/6J)
abnormal melanogenesis J:5346
a/a
Tyrc/Tyrem2Ove

(involves: C57BL/6 * FVB)
decreased eye pigmentation J:94077
diluted coat color J:94077
a/a
Tyrc/Tyrem4Ove

(involves: C57BL/6 * FVB)
abnormal eye pigmentation J:94077
diluted coat color J:94077
a/a
Tyrc/Tyrem9Ove

(involves: C57BL/6 * FVB)
diluted coat color J:94077
a/a
Tyrc/Tyrem14Ove

(involves: C57BL/6 * FVB)
diluted coat color J:94077
a/a
Tyrem2Ove/Tyrem2Ove

(involves: C57BL/6 * FVB)
abnormal eye pigmentation J:94077
abnormal tail pigmentation J:94077
diluted coat color J:94077
a/a
Tyrem4Ove/Tyrem4Ove

(involves: C57BL/6 * FVB)
abnormal eye pigmentation J:94077
decreased tail pigmentation J:94077
diluted coat color J:94077
a/a
Tyrem14Ove/Tyrem14Ove

(involves: C57BL/6 * FVB)
diluted coat color J:94077
a/a
Tyrp1B-lt/Tyrp1+

(Not Specified)
abnormal dorsoventral coat patterning J:13094
abnormal hair shaft melanin granule distribution J:13094
abnormal hair shaft melanin granule morphology J:13094
reduced hair shaft melanin granule number J:13094
a/a
Tyrp1B-lt/Tyrp1B-lt

(Not Specified)
abnormal dorsoventral coat patterning J:13094
abnormal hair follicle melanin granule morphology J:13094
abnormal hair shaft melanin granule distribution J:13094
abnormal hair shaft melanin granule morphology J:13094
enlarged hair follicle melanin granules J:13094
reduced hair shaft melanin granule number J:13094
a/a
Tyrp1b/Tyrp1b

(involves: C57BL/6J)
abnormal melanosome morphology J:5346
a/a
Tyrp1b/Tyrp1b

(Not Specified)
abnormal coat/hair pigmentation J:12970
abnormal eye pigmentation J:12970
abnormal melanocyte morphology J:12970
a/a
Tyrp1b/Tyrp1b
wad/wad

(Not Specified)
diluted coat color J:162146
a/a
Tyrp1b/Tyrp1b
wad/wad+

(Not Specified)
diluted coat color J:162146
a/a
U/U

(Not Specified)
abnormal coat/hair pigmentation J:78801
darkened coat color J:78801
a/a
Zc3h4KK/Zc3h4KK

(involves: C57BL/6J * KK-Ay)
increased body weight J:48704
a/A
Mc1re/Mc1re
Pomctm1Sora/Pomctm1Sora
Tg(MC1R)1Jkn/?

(involves: 129S6/SvEvTac * C57BL/6Ha)
abnormal hair follicle pheomelanosome pheomelanin content J:129904
yellow coat color J:129904
a/A
Pomctm1Sora/Pomctm1Sora

(involves: 129S6/SvEvTac)
abnormal hair follicle pheomelanosome pheomelanin content J:129904
yellow coat color J:129904
a/a6H
(involves: 101/H * C3H/HeH)
abnormal pinna hair pigmentation J:5021
darkened coat color J:5021
a/a13H
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:90559
a/a17H
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:90559
a/a19H
(involves: C3H/HeH)
abnormal coat/hair pigmentation J:90559
a/a20H
(Not Specified)
abnormal coat/hair pigmentation J:90559
a/atwp
(Not Specified)
abnormal coat/hair pigmentation J:16568
abnormal ventral coat pigmentation J:16568
a/Aw-20J
(involves: C57BL/6J)
abnormal coat/hair pigmentation J:79402
abnormal ventral coat pigmentation J:79402
a/Aw-22J
(involves: C57BL/10GnDgWtRk)
abnormal coat/hair pigmentation J:79402
abnormal ventral coat pigmentation J:79402
a/Ay
Bwq2KK/Bwq2KK

(involves: C57BL/6J * KK-Ay)
increased body weight J:131439, J:93199
increased susceptibility to weight gain J:93199
a/Ay
Bwq10C57BL/6J/Bwq10C57BL/6J

(involves: C57BL/6J * KK-Ay)
increased body weight J:131439
a/Ay
Guq1KK/Guq1KK

(involves: C57BL/6J * KK-Ay)
increased urine glucose level J:131439
a/Ay
Guq2C57BL/6J/Guq2C57BL/6J

(involves: C57BL/6J * KK-Ay)
increased urine glucose level J:131439
a/Ay
Zc3h4C57BL/6J/Zc3h4KK

(involves: C57BL/6J * KK-Ay)
increased body weight J:48704
a/Ay
Zc3h4KK/Zc3h4KK

(involves: C57BL/6J * KK-Ay)
increased body weight J:131439, J:48704
A/?
DctSlt-lt/Dct+

(involves: C3H/HeJ)
diluted coat color J:27515
A/?
DctSlt-lt/DctSlt-lt

(involves: C3H/HeJ)
diluted coat color J:27515
A/?
Lystbg/Lystbg
Tyrp1+/?

(Not Specified)
abnormal eye pigmentation J:29744
decreased ear pigmentation J:29744
decreased tail pigmentation J:29744
diluted coat color J:29744
irregular coat pigmentation J:29744
A/?
Lystbg/Lystbg
Tyrp1b/Tyrp1b

(Not Specified)
decreased eye pigmentation J:29744
diluted coat color J:29744
A/?
Tyrc/Tyrem1Ove

(involves: C57BL/6 * FVB)
decreased eye pigmentation J:94077
diluted coat color J:94077
A/?
Tyrc/Tyrem6Ove

(involves: C57BL/6 * FVB)
diluted coat color J:94077
variegated eye pigmentation pattern J:94077
A/?
Tyrc/Tyrem7Ove

(involves: C57BL/6 * FVB)
diluted coat color J:94077
A/?
Tyrc/Tyrem12Ove

(involves: C57BL/6 * FVB)
diluted coat color J:94077
A/?
Tyrc/Tyrem13Ove

(involves: C57BL/6 * FVB)
pigmentation phenotype J:94077
A/?
Tyrem1Ove/Tyrem1Ove

(involves: C57BL/6 * FVB)
diluted coat color J:94077
A/?
Tyrem7Ove/Tyrem7Ove

(involves: C57BL/6 * FVB)
abnormal eye pigmentation J:94077
diluted coat color J:94077
A/?
Tyrem8Ove/Tyrem8Ove

(involves: C57BL/6 * FVB)
decreased ear pigmentation J:94077
decreased tail pigmentation J:94077
diluted coat color J:94077
variegated eye pigmentation pattern J:94077
A/?
Tyrem9Ove/Tyrem9Ove

(involves: C57BL/6 * FVB)
decreased eye pigmentation J:94077
diluted coat color J:94077
A/?
Tyrem12Ove/Tyrem12Ove

(involves: C57BL/6 * FVB)
decreased eye pigmentation J:94077
diluted coat color J:94077
A/?
Tyrem13Ove/Tyrem13Ove

(involves: C57BL/6 * FVB)
pigmentation phenotype J:94077
A/a
In(11Trp53;11Wnt3)8Brd/+

(either: (involves: 129S7/SvEvBrd * C57BL/6Brd) or (involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6Brd) or (involves: 129S5/SvEvBrd * C57BL/6Brd * C57BL/6J))
abnormal tail pigmentation J:56548
decreased ear pigmentation J:56548
A/a
Tyrem15Ove/Tyrem15Ove

(involves: C57BL/6 * FVB)
decreased tail pigmentation J:94077
diluted coat color J:94077
A/a
Tyrp1B-lt/Tyrp1B-lt

(Not Specified)
diluted coat color J:13094
A/A
(Not Specified)
no abnormal phenotype detected J:36414
pigmentation phenotype J:36414
A/A
Dkd/Dkd

(LPT;C3-Dkd/GrsrJ)
abnormal dorsoventral coat patterning J:137334
hearing/vestibular/ear phenotype J:137334
vision/eye phenotype J:137334
A/A
Hps6ru/Hps6ru

(Not Specified)
diluted coat color J:13122
A/A
Mc1rE-tob/Mc1r+

(M. m. domesticus poschiavinus)
abnormal coat/hair pigmentation J:22593
darkened coat color J:22593
A/A
Mc1rE-tob/Mc1rE-tob

(M. m. domesticus poschiavinus)
abnormal coat/hair pigmentation J:22593
darkened coat color J:22593
A/A
Tyrc-ch/Tyrc-ch

(Not Specified)
abnormal coat appearance J:36414
abnormal coat/hair pigmentation J:36414
abnormal hair follicle pheomelanosome pheomelanin content J:36414
A/A
U/U

(Not Specified)
abnormal coat/hair pigmentation J:78801
darkened coat color J:78801, J:280
A/atl
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:169366
A/atwp
(Not Specified)
abnormal coat/hair pigmentation J:16568
abnormal ventral coat pigmentation J:16568
A1cfTg(Myh6-cre/Esr1*)1Jmk/0
(involves: 129S/Sv * C57BL/6 * FVB/N)
abnormal myocardium layer morphology J:164749
decreased cardiac muscle contractility J:164749
dilated cardiomyopathy J:164749
A1cfTg(Myh6-cre/Esr1*)1Jmk/?
Slc25a3tm1.1Jmol/Slc25a3tm1.1Jmol

(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
abnormal calcium ion homeostasis J:229795
abnormal cardiac muscle tissue morphology J:229795
abnormal channel response J:229795
abnormal mitochondrial ATP synthesis coupled electron transport J:229795
abnormal sarcomere morphology J:229795
cardiac hypertrophy J:229795
cardiomyopathy J:229795
decreased cardiac muscle contractility J:229795
increased heart weight J:229795
increased mitochondrial fission J:229795
A1cfTg(Myh6-cre/Esr1*)1Jmk/?
Tnni3ktm1Tfo/Tnni3ktm1Tfo

(involves: C57BL/6 * FVB/N)
increased myocardial fiber number J:249318
A1cfTg(Myh6-cre/Esr1*)1Jmk/0
Tspotm1.1Maf/Tspotm1.1Maf

(involves: C57BL/6 * FVB/N)
cardiovascular system phenotype J:214129
A1cftm1Ddsn/A1cftm1Ddsn
(involves: 129X1/SvJ)
decreased cell proliferation J:114732
embryonic lethality before implantation, complete penetrance J:114732
A3galt2tm1.1Hjg/A3galt2tm1.1Hjg
(involves: 129P2/OlaHsd * BALB/cJ)
immune system phenotype J:120323
no abnormal phenotype detected J:120323
A4galttm1.1Poru/A4galttm1.1Poru
Glatm1Kul/Glatm1Kul

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
immune system phenotype J:189359
A4galttm1Kfk/A4galttm1Kfk
(involves: C57BL/6)
decreased physiological sensitivity to xenobiotic J:108352
decreased sensitivity to xenobiotic induced morbidity/mortality J:108352
impaired behavioral response to xenobiotic J:108352
A4gnttm1Jnaka/A4gnttm1Jnaka
(B6.129S6-A4gnttm1Jnaka)
abnormal digestive system physiology J:184485
abnormal stomach mucosa morphology J:184485
increased angiogenesis J:184485
increased cell proliferation J:184485
increased gastric adenocarcinoma incidence J:184485
increased tumor growth/size J:184485
stomach epithelial hyperplasia J:184485
stomach inflammation J:184485
A430005L14Riktm1a(KOMP)Wtsi/A430005L14Riktm1a(KOMP)Wtsi
(C57BL/6N-A430005L14Riktm1a(KOMP)Wtsi/Wtsi)
decreased circulating insulin level J:211773
A830005F24Riktm1.1(KOMP)Mbp/A830005F24Rik+
(C57BL/6N-A830005F24Riktm1.1(KOMP)Mbp/Ucd)
abnormal heart morphology J:211773
abnormal kidney morphology J:211773
abnormal seminal vesicle morphology J:211773
enlarged heart J:211773
enlarged kidney J:211773
A830005F24Riktm1.1(KOMP)Mbp/A830005F24Riktm1.1(KOMP)Mbp
(C57BL/6N-A830005F24Riktm1.1(KOMP)Mbp/Ucd)
abnormal heart morphology J:211773
enlarged heart J:211773
A830019P07Riktm1a(KOMP)Wtsi/A830019P07Riktm1a(KOMP)Wtsi
(C57BL/6N-A830019P07Riktm1a(KOMP)Wtsi/Wtsi)
decreased circulating insulin level J:211773
A830031A19Riktm1b(KOMP)Wtsi/A830031A19Riktm1b(KOMP)Wtsi
(C57BL/6N-A830031A19Riktm1b(KOMP)Wtsi/Wtsi)
decreased circulating insulin level J:211773
decreased total body fat amount J:211773
increased lean body mass J:211773
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur
(involves: 129S6/SvEvTac)
abnormal cone electrophysiology J:179784
abnormal hippocampus granule cell morphology J:179784
abnormal retinal apoptosis J:179784
abnormal retinal cone cell morphology J:179784
decreased brain size J:179784
decreased brain weight J:179784
decreased retinal cone cell number J:179784
increased neuron apoptosis J:179784
limb grasping J:179784
nervous system phenotype J:179784
postnatal lethality, incomplete penetrance J:179784
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur
Tg(Crx-DsRed,-Mir124a-2)#Tfur/0

(involves: 129S6/SvEvTac * C3H * C57BL/6)
vision/eye phenotype J:179784
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur
Tg(Syn1-DsRed,-Mir124a-2)#Tfur/0

(involves: 129S6/SvEvTac * C3H * C57BL/6)
nervous system phenotype J:179784
a1R/a1R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a2R/a2R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a3R/a3R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a4R/a4R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a5mnu/a5mnu
(involves: 101/H * C3H/HeH)
abnormal coat appearance J:16567
darkened coat color J:16567
a5R/a5R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a6H/a6H
(involves: 101/H * C3H/HeH)
abnormal pinna hair pigmentation J:5021
darkened coat color J:5021
a6R/a6R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a7R/a7R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a8R/a8R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a9R/a9R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a10R/a10R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a11R/a11R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a12R/a12R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a13H/a13H
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:90559
abnormal pinna hair pigmentation J:90559
a13R/a13R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a14R/a14R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a15R/a15R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a16H/a16H
(involves: 101/H * C3H/HeH)
prenatal lethality J:8093
a16H/ae
(involves: 101/H * C3H/HeH * P * S)
abnormal coat/hair pigmentation J:8093
a16H/al
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:9799
a16R/a16R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a17H/a17H
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:90559
abnormal pinna hair pigmentation J:90559
a17R/a17R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a18R/a18R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a19H/a19H
(involves: C3H/HeH)
abnormal coat/hair pigmentation J:90559
abnormal pinna hair pigmentation J:90559, J:181531
a19R/a19R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a20H/a20H
(Not Specified)
abnormal coat/hair pigmentation J:90559
abnormal pinna hair pigmentation J:90559
abnormal tail hair pigmentation J:90559
a20R/a20R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a21R/a21R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a22R/a22R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a23R/a23R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a24R/a24R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a25R/a25R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
ada/ada
(involves: 101/H * C3H/HeH)
abnormal dorsoventral coat patterning J:13694
abnormal pinna hair pigmentation J:163587
darkened coat color J:13694
ae/ae
((P x S)F1)
abnormal coat/hair pigmentation J:13070
darkened coat color J:13070
ae/ae
Tbx15de-H/Tbx15de-H

(involves: BTBR * C3H/HeJ * C57BL/6 * P * S)
abnormal skeleton morphology J:87455
abnormal skin pigmentation J:87455
decreased body size J:87455
integument phenotype J:87455
short hair J:87455
Ahvy/A
(B6.C3-Bpifa2a Ahvy)
abnormal coat/hair pigmentation J:24247
darkened coat color J:24247
irregular coat pigmentation J:24247
yellow coat color J:24247
Ahvy/Ahvy
(B6.C3-Bpifa2a Ahvy)
abnormal coat/hair pigmentation J:24247
Aiapy/?
(involves: C3H/HeJ * C57BL/6J)
abnormal coat/hair pigmentation J:18848
irregular coat pigmentation J:18848
maternal effect J:18848
mottled coat J:18848
obese J:18848
yellow coat color J:18848
Aiapy/Aiapy
(involves: C3H/HeJ * C57BL/6J)
abnormal coat/hair pigmentation J:18848
irregular coat pigmentation J:18848
mortality/aging J:18848
mottled coat J:18848
obese J:18848
yellow coat color J:18848
Aiy/A
(C3H/HeJ-Aiy)
abnormal coat/hair pigmentation J:30922
mottled coat J:30922
obese J:30922
yellow coat color J:30922
Aiy/Aiy
(C3H/HeJ-Aiy)
abnormal coat/hair pigmentation J:30922
mottled coat J:30922
obese J:30922
yellow coat color J:30922
ajIs(17;In2)1Gso/ajIs(17;In2)1Gso
Fmn1ld-Is(17;In2)1Gso/Fmn1ld-Is(17;In2)1Gso

(involves: 101/Rl * C3H/Rl * C57BL/E * SEC/Rl)
abnormal autopod morphology J:10399
abnormal carpal bone morphology J:10399
abnormal forelimb morphology J:10399
abnormal hindlimb morphology J:10399
abnormal patella morphology J:10399
abnormal radius morphology J:10399
abnormal tarsal bone morphology J:10399
abnormal ulna morphology J:10399
absent fibula J:10399
brachydactyly J:10399
darkened coat color J:10399
dilated ureter J:10399
fused carpal bones J:10399
fused tarsal bones J:10399
hydronephrosis J:10399
hydroureter J:10399
oligodactyly J:10399
radius hypoplasia J:10399
renal hypoplasia J:10399
single kidney J:10399
syndactyly J:10399
synostosis J:10399
ajl10/a
(Not Specified)
darkened coat color J:16567
ajl10/ajl10
(Not Specified)
prenatal lethality J:16567
ajl41/a
(Not Specified)
darkened coat color J:16567
ajl41/ajl41
(Not Specified)
prenatal lethality J:16567
ajl85/a
(Not Specified)
darkened coat color J:16567
ajl85/ajl85
(Not Specified)
prenatal lethality J:16567
al/a
(involves: 101/H * C3H/HeH)
pigmentation phenotype J:9799
al/al
(involves: 101/H * C3H/HeH)
prenatal lethality J:9799
am-J/a
(involves: C3H/HeJ * C57BL/6J)
mottled coat J:16570
am-J/am-J
(involves: C3H/HeJ * C57BL/6J)
maternal imprinting J:16570
mottled coat J:16570
am/a
(involves: 101/Rl * C3H/Rl)
irregular coat pigmentation J:29504, J:5964
maternal effect J:5964
mottled coat J:29504
Amhdadcc4/Amhdadcc4
(C3FeJ.Cg-Amhdadcc4/Ieg)
darkened coat color J:81301
Asy/a
(C57BL/6J-Asy/a/J)
yellow coat color J:13497
Asy/Asy
(C57BL/6J-Asy/a/J)
yellow coat color J:13497
at-2Gso/at-2Gso
(involves: C57BL/RlGso * SEC/RlGso)
abnormal coat/hair pigmentation J:3523
at-33J/at-33J
(C57BL/6J-at-33J/J)
abnormal dorsoventral coat patterning J:78801
at-41J/at-41J
(involves: AKR/J * C57L/J)
abnormal coat appearance J:78801, J:30778
abnormal ventral coat pigmentation J:30778
at-42J/?
(C57BL/6J-at-42J)
abnormal coat/hair pigmentation J:8876
abnormal ventral coat pigmentation J:78379
at-43J/at-43J
(involves: C3HeB/FeJLe)
abnormal coat appearance J:78801, J:30778
abnormal ventral coat pigmentation J:30778
at-44J/?
(B6.C/(HZ18)By)
abnormal coat/hair pigmentation J:78379
abnormal ventral coat pigmentation J:78379
at/A
As/As+

(Not Specified)
abnormal coat/hair pigmentation J:5027
at/at
(Not Specified)
abnormal coat/hair pigmentation J:78801
abnormal dorsoventral coat patterning J:78801, J:22600
at/at
As/As

(Not Specified)
abnormal coat/hair pigmentation J:5027
darkened coat color J:5027
at/at
Tbx15de-H/Tbx15de-H

(involves: BTBR * C3H/HeJ * C57BL/6)
abnormal dorsoventral coat patterning J:87455
abnormal ventral coat pigmentation J:87455
broad nasal bridge J:87455
decreased body size J:87455
irregular coat pigmentation J:87455
lowered ear position J:87455
narrow eye opening J:87455
ocular hypertelorism J:87455
shortened head J:87455
at/atl
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:169366
atd/a
(C57BL/6J-atd/J)
abnormal coat/hair pigmentation J:13082
abnormal dorsoventral coat patterning J:13082
abnormal ventral coat pigmentation J:13082
atd/atd
(C57BL/6J-atd/J)
abnormal coat/hair pigmentation J:13082
abnormal dorsoventral coat patterning J:13082
abnormal ventral coat pigmentation J:13082
atl/atl
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:169366
darkened coat color J:169366
Atm1.1Arte/a
(C57BL/6NTac-Atm1.1Arte/a)
integument phenotype J:213411
phenotypic reversion J:213411
pigmentation phenotype J:213411
Atm1.1Arte/Atm1.1Arte
Tyrtm1Arte/Tyrtm1Arte

(C57BL/6NTac-Atm1.1Arte Tyrtm1Arte)
absent coat pigmentation J:213411
absent eye pigmentation J:213411
Atm1Brd/a
(C57BL/6N-Atm1Brd)
integument phenotype J:149352
pigmentation phenotype J:149352
Atm1Brd/Atm1Brd
(C57BL/6N-Atm1Brd)
integument phenotype J:149352
pigmentation phenotype J:149352
atwp/atwp
(involves: AB/Hum-1)
abnormal coat/hair pigmentation J:16568
abnormal ventral coat pigmentation J:16568
au/a
((C3H/HeH x 101/H)F1)
abnormal coat/hair pigmentation J:13694
au/au
((C3H/HeH x 101/H)F1)
abnormal coat/hair pigmentation J:13694
Avy/?
(129S1.C3-Avy)
neoplasm J:146879
Avy/a
(involves: C3H/HeJ * C57BL/6)
abnormal coat/hair pigmentation J:117156
abnormal epigenetic regulation of gene expression J:117156
increased tumor incidence J:117156
obese J:117156
variegated coat color J:117156
Avy/a
(involves: C57BL/6J)
abnormal epigenetic regulation of gene expression J:82396
variegated coat color J:82396
Avy/a
Axin1Fu/Axin1+

(involves: 129P4/RrRk * C67BL/6J)
genetic imprinting J:82396
Avy/A
Dnmt1MommeD2/Dnmt1+

(involves: C57BL/6J * FVB/NJ)
yellow coat color J:99816
Avy/A
Smarca5MommeD4/Smarca5+

(involves: C57BL/6J * FVB/NJ)
mottled coat J:99816
Avy/A
Smchd1MommeD1/Smchd1+

(involves: C57BL/6J * FVB/NJ)
yellow coat color J:99816
Avy/Avy
(involves: C3H/HeJ)
abnormal coat/hair pigmentation J:13080
Avy/Aw
(129S1.C3-Avy/Aw Chr 19MOLF/Ei)
neoplasm J:146879
Aw-15J/a
(involves: C57BL/6J * DBA/2J)
abnormal coat/hair pigmentation J:78474
abnormal ventral coat pigmentation J:78474
Aw-26J/a
(C57BL/6J-Aw-26J/a)
abnormal coat/hair pigmentation J:78801
abnormal ventral coat pigmentation J:78801
Aw-27J/a
(C57BL/6J-Aw-27J)
abnormal coat/hair pigmentation J:78801
abnormal ventral coat pigmentation J:78801
Aw-34J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-35J/?
(involves: C57BL)
absent coat pigmentation J:16984
Aw-36J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-37J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-38J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-39J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-40J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-41J/?
(involves: C57BL)
absent coat pigmentation J:16984
Aw-42J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-43J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-46J/a
(C57BL/6J-Aw-46J)
abnormal coat/hair pigmentation J:77218
abnormal skin pigmentation J:77218
Aw-46J/Aw-46J
(C57BL/6J-Aw-46J)
abnormal coat/hair pigmentation J:77218
abnormal skin pigmentation J:77218
Aw-47J/A
(C57BL/6J-Aw-47J)
abnormal coat/hair pigmentation J:77218
abnormal skin pigmentation J:77218
Aw-47J/Aw-47J
(C57BL/6J-Aw-47J)
abnormal coat/hair pigmentation J:77218
abnormal skin pigmentation J:77218
Aw-J/Aw-J
(C57BL/6J-Aw-J/J)
abnormal hair follicle melanogenesis J:1295
abnormal ventral coat pigmentation J:30922
decreased circulating pituitary hormone level J:52183
Aw/?
(Not Specified)
abnormal ventral coat pigmentation J:78801, J:22600
yellow coat color J:22600
Aw/a
(involves: SM/J)
endocrine/exocrine gland phenotype J:19308
Aw/a
Corintm1Bamo/Corintm1Bamo

(involves: 129X1/SvJ * C57BL/6 * FVB/N)
diluted coat color J:130426
Aw/at
As/As+

(Not Specified)
abnormal coat/hair pigmentation J:5027
Aw/Aw
(involves: SM/J)
abnormal adrenal gland x-zone morphology J:19308
endocrine/exocrine gland phenotype J:19308
Aw/Aw
As/As

(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:5027
darkened coat color J:5027
Aw/Aw
Corintm1Bamo/Corintm1Bamo

(involves: 129X1/SvJ * C57BL/6 * FVB/N)
diluted coat color J:130426
ax/a
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:174047
abnormal ventral coat pigmentation J:174047
ax/a
(B6.Cg-ax)
abnormal coat/hair pigmentation J:11953
abnormal ventral coat pigmentation J:11953
ax/ae
(B6.Cg-ax)
abnormal coat/hair pigmentation J:11953
abnormal ventral coat pigmentation J:11953
ax/ax
(B6.Cg-ax)
embryonic growth retardation J:11953
embryonic lethality between implantation and placentation, complete penetrance J:11953
ax/ax
(involves: 101/Rl * C3H/Rl)
embryonic lethality J:174047
Ay-J/?
(C3HeB/FeJ-Ay-J)
yellow coat color J:78380
Ay-Jkn/A
(involves: C57BL/6N)
yellow coat color J:129904
Ay-Jkn/A
Mc1re/Mc1re

(involves: C57BL/6Ha * C57BL/6N)
yellow coat color J:129904
Ay-Jkn/A
Mc1re/Mc1re
Tg(MC1R)1Jkn/0

(involves: C57BL/6Ha * C57BL/6N)
yellow coat color J:129904
Ay/a
(involves: KK)
abnormal lipid homeostasis J:26460
abnormal pancreatic islet morphology J:26460
abnormal renal glomerulus morphology J:26460
abnormal renal tubule morphology J:26460
degranulated pancreatic beta cells J:26460
dilated renal tubules J:26460
expanded mesangial matrix J:26460
hyperglycemia J:26460
impaired glucose tolerance J:26460
increased circulating insulin level J:26460
increased renal glomerulus basement membrane thickness J:26460
increased susceptibility to weight gain J:26460
increased total body fat amount J:26460
increased urine glucose level J:26460
insulin resistance J:26460
renal cast J:26460
Ay/a
(B6.Cg-Ay/J)
abnormal food intake J:102986
abnormal hair follicle melanogenesis J:1295
Ay/a
Agrptm2(DTR)Rpa/Agrp+

(involves: 129S4/SvJaeSor * KK/Upj)
abnormal eating behavior J:132184
decreased body weight J:132184
Ay/a
Apoetm1Unc/Apoetm1Unc

(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
abnormal glomerular mesangium morphology J:177084
abnormal inflammatory response J:177084
abnormal kidney morphology J:177084
atherosclerotic lesions J:177084
decreased circulating adiponectin level J:177084
glomerulosclerosis J:177084
hyperglycemia J:177084
increased circulating cholesterol level J:177084
increased circulating insulin level J:177084
increased circulating leptin level J:177084
increased circulating triglyceride level J:177084
increased monocyte cell number J:177084
insulin resistance J:177084
obese J:177084
Ay/a
Apoetm1Unc/Apoetm1Unc
Ccr2tm1Mae/Ccr2tm1Mae

(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
decreased circulating adiponectin level J:177084
homeostasis/metabolism phenotype J:177084
increased circulating cholesterol level J:177084
increased circulating leptin level J:177084
Ay/a
Dmbx1tm1Sse/Dmbx1tm1Sse

(involves: ICR)
decreased body weight J:125193
Ay/a
Ednrbs/Ednrbs

(Not Specified)
variable body spotting J:12954
Ay/a
Mssq1KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq2C57BL/6JJcl/Mssq2KK/TaJcl

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq3KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq4KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq5C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq6C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq6KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq7KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq9C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq10KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq11KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq12KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq13C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq13KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq14KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Mssq16KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
large mandible J:143893
Ay/a
Npbwr1tm1Rck/Npbwr1tm1Rck

(involves: 129P/Ola * C57BL/6J)
obese J:94820
Ay/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+

(involves: C57BL/6 * KK)
abnormal eating behavior J:168271
adipose tissue phenotype J:168271
decreased body weight J:168271
decreased circulating glucose level J:168271
decreased liver weight J:168271
improved glucose tolerance J:168271
Ay/a
Sik2tm1Htake/Sik2+

(C57BL/6-Sik2tm1Htake)
darkened coat color J:215877
Ay/a
Tg(tetO-Ppargc1a)1Dpk/0
Tg(Tyr-rtTA)37Lc/0

(involves: FVB)
abnormal hair follicle melanogenesis J:194191
darkened coat color J:194191
Ay/a
Tyrp1B-lt/?

(Not Specified)
yellow coat color J:13094
Ay/A
(involves: C57BL/6)
hypoactivity J:131039
increased body length J:131039
increased brown adipose tissue amount J:131039
increased circulating leptin level J:131039
increased food intake J:131039
increased gonadal fat pad weight J:131039
increased inguinal fat pad weight J:131039
increased liver weight J:131039
increased percent body fat/body weight J:131039
increased retroperitoneal fat pad weight J:131039
increased susceptibility to weight gain J:131039
obese J:131039
yellow coat color J:131039
Ay/A
(involves: C3H/HeJ * C57BL/6J-Ay/a)
yellow coat color J:30778
Ay/A
Pepddal/Pepddal

(involves: C3H/HeJ * CBA/J)
darkened coat color J:143333
obese J:143333
Ay/A
Prkar2btm2Gsm/Prkar2b+

(involves: C57BL/6)
increased percent body fat/body weight J:131039
increased susceptibility to weight gain J:131039
polyphagia J:131039
Ay/A
Prkar2btm2Gsm/Prkar2btm2Gsm

(involves: C57BL/6)
behavior/neurological phenotype J:131039
growth/size/body region phenotype J:131039
hyperactivity J:131039
increased brown adipose tissue amount J:131039
increased gonadal fat pad weight J:131039
increased inguinal fat pad weight J:131039
increased percent body fat/body weight J:131039
increased retroperitoneal fat pad weight J:131039
increased susceptibility to weight gain J:131039
yellow coat color J:131039
Ay/Aw
(129S1.C3-Ay/Aw Chr 19MOLF/Ei)
decreased incidence of induced tumors J:146879
increased body weight J:146879
Ay/Ay
(101-Ay)
embryonic lethality J:174504
embryonic lethality at implantation, complete penetrance J:174504
maternal effect J:174504
Aaastm1Ahue/Aaastm1Ahue
(involves: 129P2/OlaHsd * C57BL/6)
abnormal motor coordination/balance J:106908
cellular phenotype J:106908
decreased body weight J:106908
decreased exploration in new environment J:106908
digestive/alimentary phenotype J:106908
endocrine/exocrine gland phenotype J:106908
female infertility J:106908
homeostasis/metabolism phenotype J:106908
hypoactivity J:106908
nervous system phenotype J:106908
AabprNZB/Slc/?
(involves: NZB/Slc * NZW/Slc)
increased B cell proliferation J:87690
Aadattm1Tag/Aadattm1Tag
(either: (involves: 129S/SvEv) or (involves: 129S/SvEv * Black Swiss))
abnormal neuron morphology J:92240
altered righting response J:92240
early eyelid opening J:92240
hyperactivity J:92240
impaired balance J:92240
Aaj1A/J/?
(involves: C57BL/6J * C57BL/6J-Chr1A/J)
increased anxiety-related response J:96389
Aaj2A/J/Aaj2A/J
(involves: C57BL/6J * C57BL/6J-Chr6A/J)
increased anxiety-related response J:96389
Aaj3A/J/Aaj3A/J
(involves: C57BL/6J * C57BL/6J-Chr6A/J)
increased anxiety-related response J:96389
Aaj4A/J/?
(involves: C57BL/6J * C57BL/6J-Chr17A/J)
increased anxiety-related response J:96389
Aak1tm1b(EUCOMM)Hmgu/Aak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Aak1tm1b(EUCOMM)Hmgu/Orl)
abnormal behavior J:211773
abnormal heart left ventricle morphology J:211773
abnormal retinal outer nuclear layer morphology J:211773
decreased circulating serum albumin level J:211773
decreased circulating total protein level J:211773
decreased grip strength J:211773
hyperactivity J:211773
increased circulating alkaline phosphatase level J:211773
increased mean corpuscular volume J:211773
increased or absent threshold for auditory brainstem response J:211773
increased vertical activity J:211773
preweaning lethality, incomplete penetrance J:211773
short tibia J:211773
Aal/?
(multiple strains)
abnormal active avoidance behavior J:8831, J:5380
AanatC57BL/6J/AanatC57BL/6J
(C57BL/6J)
abnormal pineal gland melatonin secretion J:27126
abnormal pineal gland physiology J:27126
Aaom1MRL/MpJ/Aaom1MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
vasculitis J:83832
Aapb/?
(involves: C57BL/6J)
abnormal active avoidance behavior J:5554
Aapd/?
(involves: DBA/2J)
abnormal active avoidance behavior J:5554
Aaq1C57BL/6J/Aaq1C57BL/6J
(involves: C57BL/6J * DBA/2J)
abnormal alcohol consumption J:43654
Aaq1C57BL/6J/Aaq1DBA/2J
(involves: C57BL/6J * DBA/2J)
abnormal alcohol consumption J:43654
Aars2tm1(KOMP)Wtsi/Aars2+
(C57BL/6N-Aars2tm1(KOMP)Wtsi/Nju)
abnormal heart left ventricle morphology J:211773
decreased red blood cell distribution width J:211773
impaired pupillary reflex J:211773
increased basophil cell number J:211773
Aars2tm1(KOMP)Wtsi/Aars2tm1(KOMP)Wtsi
(C57BL/6N-Aars2tm1(KOMP)Wtsi/Nju)
preweaning lethality, complete penetrance J:211773
Aarssti/Aarssti
(B6.Cg-Aarssti/J)
abnormal hair shaft morphology J:110647
ataxia J:110647
disheveled coat J:110647
focal hair loss J:110647
hair follicle degeneration J:110647
hair follicle outer root sheath hyperplasia J:110647
impaired balance J:110647
nervous system phenotype J:220153
Purkinje cell degeneration J:110647
tremors J:110647
Aarssti/Aarssti
Ankrd16rs251476964-A/Ankrd16rs251476964-A

(involves: C57BL/6J * CAST/Ei)
ataxia J:262421
Purkinje cell degeneration J:262421
Aarssti/Aarssti
Ankrd16rs251476964-A/Ankrd16rs251476964-G

(involves: C57BL/6J * CASA/RkJ)
behavior/neurological phenotype J:262421
nervous system phenotype J:262421
neuron degeneration J:262421
Aarssti/Aarssti
Ankrd16rs251476964-G/Ankrd16rs251476964-G

(involves: C57BL/6J * CAST/Ei)
behavior/neurological phenotype J:262421
nervous system phenotype J:262421
Aarssti/Aarssti
Ankrd16tm1.1Slac/Ankrd16tm1.1Slac

(B6.Cg-Ankrd16tm1.1Slac Aarssti)
embryonic lethality during organogenesis, complete penetrance J:262421
Aarssti/Aarstm1.1Slac
(involves: C57BL/6J * FVB/N)
abnormal myocardial fiber morphology J:216802
alopecia J:216802
cardiac fibrosis J:216802
decreased body size J:216802
Aarssti/Aarstm1Slac
(involves: C57BL/6J)
abnormal autophagy J:216802
abnormal cardiovascular system physiology J:216802
abnormal mitochondrion morphology J:216802
abnormal myocardial fiber morphology J:216802
abnormal myocardial fiber physiology J:216802
abnormal sarcoplasmic reticulum morphology J:216802
alopecia J:216802
cardiac fibrosis J:216802
cardiac interstitial fibrosis J:216802
decreased body size J:216802
decreased body weight J:216802
decreased cardiac output J:216802
decreased ventricle muscle contractility J:216802
disorganized myocardium J:216802
Purkinje cell degeneration J:216802
small heart J:216802
thin ventricular wall J:216802
Aarstm1.1Slac/Aars+
(involves: C57BL/6J * FVB/N)
Purkinje cell degeneration J:216802
Aarstm1.1Slac/Aarstm1.1Slac
(involves: C57BL/6J * FVB/N)
embryonic lethality prior to organogenesis J:216802
Aasdhppttm1.1(KOMP)Vlcg/Aasdhppt+
(B6N(Cg)-Aasdhppttm1.1(KOMP)Vlcg/J)
decreased grip strength J:211773
Aasdhppttm1.1(KOMP)Vlcg/Aasdhppttm1.1(KOMP)Vlcg
(B6N(Cg)-Aasdhppttm1.1(KOMP)Vlcg/J)
preweaning lethality, complete penetrance J:211773
Aassem1(IMPC)Tcp/Aassem1(IMPC)Tcp
(C57BL/6NCrl-Aassem1(IMPC)Tcp/Tcp)
abnormal sternum morphology J:211773
decreased circulating cholesterol level J:211773
enlarged lymph nodes J:211773
enlarged urinary bladder J:211773
increased circulating alanine transaminase level J:211773
increased circulating aspartate transaminase level J:211773
AatfGt(pGT1.8geo)3Pgr/AatfGt(pGT1.8geo)3Pgr
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * NMRI))
abnormal cell morphology J:65741
abnormal preimplantation embryo development J:65741
absent blastocoele J:65741
decreased cell proliferation J:65741
decreased embryo size J:65741
embryonic growth arrest J:65741
embryonic lethality before implantation, complete penetrance J:65741
failure of blastocyst formation J:65741
failure of morula compaction J:65741
Aatktm1Shhi/Aatktm1Shhi
(involves: C57BL/6J)
abnormal axon morphology J:184851
abnormal axonal transport J:184851
abnormal neurite morphology J:184851
decreased brain size J:184851
Abatem2(IMPC)Bay/Abatem2(IMPC)Bay
(C57BL/6N-Abatem2(IMPC)Bay/Bay)
preweaning lethality, complete penetrance J:211773
Abbp1A/J/Abbp1C57BL/6
(involves: A/J * C57BL/6)
increased systemic arterial blood pressure J:86889
Abbp1C57BL/6/Abbp1C57BL/6
(involves: A/J * C57BL/6)
increased systemic arterial blood pressure J:86889
Abbp2C57BL/6/Abbp2C57BL/6
(involves: A/J * C57BL/6)
increased systemic arterial blood pressure J:86889
Abbp3A/J/Abbp3C57BL/6
(involves: A/J * C57BL/6)
increased systemic arterial blood pressure J:86889
Abbp3C57BL/6/Abbp3C57BL/6
(involves: A/J * C57BL/6)
increased systemic arterial blood pressure J:86889
Abbp4C57BL/6/Abbp4C57BL/6
(involves: A/J * C57BL/6)
increased systemic arterial blood pressure J:86889
Abca1m4620Dajl/Abca1+
(involves: C3H/HeSnJ * C57BL/6J * SWR)
decreased circulating cholesterol level J:149088
decreased circulating HDL cholesterol level J:149088
Abca1m4620Dajl/Abca1m4620Dajl
(involves: C3H/HeSnJ * C57BL/6J * SWR)
decreased circulating cholesterol level J:149088
decreased circulating HDL cholesterol level J:149088
increased circulating triglyceride level J:149088
Abca1mpc227H/Abca1mpc227H
(involves: BALB/c * C3H/HeH * C57BL/6J)
decreased circulating cholesterol level J:234901
Abca1tm1.1Jp/Abca1tm1.1Jp
(involves: 129S6/SvEvTac * C57BL/6)
abnormal circulating phospholipid level J:98093
decreased circulating cholesterol level J:98093
decreased circulating HDL cholesterol level J:98093
Abca1tm1b(EUCOMM)Hmgu/Abca1+
(C57BL/6N-Abca1tm1b(EUCOMM)Hmgu/Bay)
abnormal embryo size J:211773
Abca1tm1b(EUCOMM)Hmgu/Abca1tm1b(EUCOMM)Hmgu
(C57BL/6N-Abca1tm1b(EUCOMM)Hmgu/Bay)
abnormal embryo size J:211773
preweaning lethality, complete penetrance J:211773
Abca1tm1Blt/Abca1tm1Blt
(C57BL/6-Abca1tm1Blt)
abnormal platelet physiology J:95088
Abca1tm1Jdm/Abca1+
(DBA/1LacJ-Abca1tm1Jdm)
abnormal circulating phospholipid level J:61679
abnormal lipid homeostasis J:61679
abnormal lung morphology J:61679
decreased circulating cholesterol level J:61679
decreased circulating HDL cholesterol level J:61679
decreased circulating LDL cholesterol level J:61679
Abca1tm1Jdm/Abca1tm1Jdm
(DBA/1LacJ-Abca1tm1Jdm)
abnormal circulating phospholipid level J:61679
abnormal fat-soluble vitamin level J:60210
abnormal lipid homeostasis J:61679
abnormal lung morphology J:61679
abnormal placenta development J:63265
abnormal pulmonary alveolus morphology J:61679
decreased body weight J:60210
decreased circulating cholesterol level J:60210, J:61679
decreased circulating HDL cholesterol level J:60210, J:61679
decreased circulating LDL cholesterol level J:61679
enlarged adrenal glands J:60210
enlarged spleen J:60210
female infertility J:63265
hemorrhage J:63265
impaired macrophage phagocytosis J:63265
increased intestinal cholesterol absorption J:61679
perinatal lethality, incomplete penetrance J:61679
postnatal lethality, incomplete penetrance J:63265
thrombocytopenia J:60210
Abca1tm1Jdm/Abca1tm1Jdm
(involves: DBA/1LacJ)
abnormal circulating phytosterol level J:87209
Abca1tm1Jdm/Abca1tm1Jdm
(DBA/1-Abca1tm1Jdm/J)
increased cholesterol efflux J:130777
Abca1tm1Jdm/Abca1tm1Jdm
(involves: C57BL/6 * DBA/1LacJ)
abnormal thymus morphology J:132254
decreased circulating cholesterol level J:132254
decreased circulating HDL cholesterol level J:132254
homeostasis/metabolism phenotype J:132254
impaired macrophage phagocytosis J:132254
perinatal lethality, incomplete penetrance J:132254
Abca1tm1Jdm/Abca1tm1Jdm
Abcg1tm1Dgen/Abcg1tm1Dgen

(involves: 129P2/OlaHsd * C57BL/6 * DBA/1LacJ)
abnormal chemokine secretion J:130777
abnormal cytokine secretion J:130777
decreased cholesterol efflux J:130777
Abca1tm1Jdm/Abca1tm1Jdm
Abcg1tm1Dgen/Abcg1tm1Dgen

(involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)
abnormal bone marrow cell morphology/development J:190966
abnormal bone structure J:190966
abnormal common myeloid progenitor cell morphology J:190966
abnormal hematopoietic system physiology J:190966
decreased monocyte cell number J:190966
extramedullary hematopoiesis J:190966
increased hematopoietic stem cell number J:190966
increased monocyte cell number J:190966
increased neutrophil cell number J:190966
Abca1tm1Jdm/Abca1tm1Jdm
Abcg1tm1Dgen/Abcg1tm1Dgen
Apoetm1Unc/Apoetm1Unc

(involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)
abnormal hematopoietic system physiology J:190966
Abca1tm1Jdm/Abca1tm1Jdm
Abcg1tm1Dgen/Abcg1tm1Dgen
Tg(APOA1)1Rub/0

(involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)
abnormal hematopoietic system physiology J:190966
Abca1tm1Jdm/Abca1tm1Jdm
Tg(Thy1-APP)3Somm/0

(involves: C57BL/6J * DBA/1LacJ * DBA/2)
amyloidosis J:105902
cerebral amyloid angiopathy J:105902
intracerebral hemorrhage J:105902
preweaning lethality, incomplete penetrance J:105902
Abca1tm1Jdm/Abca1tm1Jdm
Tgm2tm1Gml/Tgm2tm1Gml

(involves: C57BL/6 * DBA/1LacJ)
abnormal thymus morphology J:132254
decreased circulating cholesterol level J:132254
decreased circulating HDL cholesterol level J:132254
homeostasis/metabolism phenotype J:132254
impaired macrophage phagocytosis J:132254
perinatal lethality J:132254
Abca1tm1Jp/Abca1+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J)
abnormal cholesterol homeostasis J:98093
abnormal circulating phospholipid level J:98093
decreased circulating cholesterol level J:98093
decreased circulating HDL cholesterol level J:98093
Abca1tm1Jp/Abca1+
Tg(Vil1-cre)997Gum/0

(involves: 129S6/SvEvTac * C57BL/6 * SJL)
decreased circulating cholesterol level J:107802
decreased circulating HDL cholesterol level J:107802
Abca1tm1Jp/Abca1tm1Jp
Abcg1tm1Tall/Abcg1tm1Tall
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
abnormal bone marrow cell morphology/development J:190966
increased interleukin-17 secretion J:190966
increased interleukin-23 secretion J:190966
Abca1tm1Jp/Abca1tm1Jp
Abcg1tm1Tall/Abcg1tm1Tall
Tg(Itgax-cre,-EGFP)4097Ach/0

(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
abnormal bone marrow cell morphology/development J:190966
increased interleukin-17 secretion J:190966
increased interleukin-23 secretion J:190966
Abca1tm1Jp/Abca1tm1Jp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J)
abnormal cholesterol homeostasis J:98093
abnormal circulating phospholipid level J:98093
decreased circulating cholesterol level J:98093
decreased circulating HDL cholesterol level J:98093
decreased circulating LDL cholesterol level J:98093
increased circulating triglyceride level J:98093
Abca1tm1Jp/Abca1tm1Jp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S6/SvEvTac * C57BL/6 * DBA)
decreased circulating HDL cholesterol level J:107802
Abca1tm1Jp/Abca1tm1Jp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(Vil1-cre)997Gum/0

(involves: 129S6/SvEvTac * C57BL/6 * DBA * SJL)
decreased circulating HDL cholesterol level J:107802
Abca1tm1Jp/Abca1tm1Jp
Tg(Vil1-cre)997Gum/0

(involves: 129S6/SvEvTac * C57BL/6 * SJL)
abnormal enterocyte physiology J:107802
decreased cholesterol efflux J:107802
decreased circulating cholesterol level J:107802
decreased circulating HDL cholesterol level J:107802
decreased circulating LDL cholesterol level J:107802
Abca1tm1Wpfl/Abca1+
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal placenta labyrinth morphology J:64390
cardiomyopathy J:64390
decreased circulating cholesterol level J:64390
decreased circulating HDL cholesterol level J:64390
heart left ventricle hypertrophy J:64390
heart right ventricle hypertrophy J:64390
lung hemorrhage J:64390
reduced female fertility J:64390
respiratory distress J:64390
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal adrenal gland morphology J:64390
abnormal kidney cortex morphology J:64390
abnormal ovary morphology J:64390
abnormal placenta labyrinth morphology J:64390
abnormal Sertoli cell morphology J:64390
abnormal thymus morphology J:64390
abnormal uterus morphology J:64390
cardiomyopathy J:64390
decreased body size J:64390
decreased circulating cholesterol level J:68431, J:64390
decreased circulating estradiol level J:64390
decreased circulating HDL cholesterol level J:68431, J:64390
decreased circulating progesterone level J:64390
decreased intestinal cholesterol absorption J:68431
embryonic growth arrest J:64390
embryonic growth retardation J:64390
glomerulonephritis J:64390
glomerulosclerosis J:64390
heart left ventricle hypertrophy J:64390
heart right ventricle hypertrophy J:64390
hepatic steatosis J:64390
lethality throughout fetal growth and development, incomplete penetrance J:64390
lung hemorrhage J:64390
postnatal lethality, incomplete penetrance J:64390
reduced female fertility J:64390
renal glomerular immunoglobulin deposits J:64390
respiratory distress J:64390
uterus inflammation J:64390
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129 * C57BL/6)
abnormal Sertoli cell morphology J:101966
Abca1tm1Wpfl/Abca1tm1Wpfl
Npc1m1N/Npc1m1N

(involves: 129P2/OlaHsd * BALB/c)
decreased brain cholesterol level J:130969
increased cholesterol level J:130969
premature death J:130969
Abca1tm2Jp/Abca1+
Tg(APOA1)427Bres/?

(involves: 129X1/SvJ * C57BL/6J * CBA/J)
abnormal circulating cholesterol level J:104719
abnormal circulating protein level J:104719
decreased circulating HDL cholesterol level J:104719
decreased circulating phospholipid level J:104719
Abca1tm2Jp/Abca1tm2Jp
Tg(APOA1)427Bres/?

(involves: 129X1/SvJ * C57BL/6J * CBA/J)
abnormal circulating cholesterol level J:104719
abnormal circulating protein level J:104719
abnormal kidney physiology J:104719
decreased circulating HDL cholesterol level J:104719
decreased circulating phospholipid level J:104719
Abca2tm1Kdt/Abca2tm1Kdt
(involves: 129)
abnormal motor coordination/balance J:117673
abnormal myelin sheath morphology J:117673
decreased body weight J:117673
enhanced coordination J:117673
hyperactivity J:117673
increased fear-related response J:117673
increased startle reflex J:117673
increased vertical activity J:117673
tremors J:117673
Abca2tm1Nina/Abca2tm1Nina
(involves: 129X1/SvJ * C57BL/6)
abnormal emotion/affect behavior J:123521
abnormal lipid level J:123521
decreased body weight J:123521
impaired balance J:123521
increased sensitivity to induced morbidity/mortality J:123521
reduced female fertility J:123521
tremors J:123521
Abca3tm1b(EUCOMM)Hmgu/Abca3tm1b(EUCOMM)Hmgu
(C57BL/6N-Abca3tm1b(EUCOMM)Hmgu/Bay)
preweaning lethality, complete penetrance J:211773
Abca3tm1Dgen/Abca3+
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal lung development J:124809
abnormal surfactant physiology J:124809
decreased alveolar lamellar body number J:124809
Abca3tm1Dgen/Abca3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal pulmonary alveolus morphology J:124809
abnormal surfactant secretion J:124809
absent alveolar lamellar bodies J:124809
neonatal lethality, complete penetrance J:124809
prenatal lethality, incomplete penetrance J:124809
thick pulmonary interalveolar septum J:124809
Abca3tm1Frm/Abca3tm1Frm
(involves: 129S/SvEv)
abnormal lipid homeostasis J:120296
abnormal surfactant secretion J:120296
absent alveolar lamellar bodies J:120296
cyanosis J:120296
lethargy J:120296
neonatal lethality, complete penetrance J:120296
primary atelectasis J:120296
pulmonary alveolar hemorrhage J:120296
renal/urinary system phenotype J:120296
respiratory failure J:120296
Abca3tm1Holz/Abca3tm1Holz
(involves: 129S6/SvEvTac * C57BL/6)
abnormal alveolar lamellar body morphology J:122736
abnormal surfactant physiology J:122736
abnormal type II pneumocyte morphology J:122736
atelectasis J:122736
cyanosis J:122736
lethargy J:122736
neonatal lethality, complete penetrance J:122736
respiratory distress J:122736
respiratory failure J:122736
Abca3tm1Nina/Abca3tm1Nina
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal alveolar lamellar body morphology J:121155
abnormal bronchiole epithelium morphology J:121155
abnormal lung development J:121155
abnormal lung saccule morphology J:121155
abnormal surfactant composition J:121155
abnormal type II pneumocyte morphology J:121155
absent alveolar lamellar bodies J:121155
absent type I pneumocytes J:121155
atelectasis J:121155
cyanosis J:121155
increased wet-to-dry lung weight ratio J:121155
neonatal lethality, complete penetrance J:121155
pulmonary vascular congestion J:121155
respiratory failure J:121155
thick lung-associated mesenchyme J:121155
Abca4tm1.1Rsmy/Abca4tm1.1Rsmy
(involves: C57BL/6)
abnormal eye physiology J:255529
abnormal retinal pigment epithelium morphology J:255529
Abca4tm1a(EUCOMM)Wtsi/Abca4+
(C57BL/6N-Abca4tm1a(EUCOMM)Wtsi/Wtsi)
increased mean corpuscular hemoglobin J:175295
Abca4tm1a(EUCOMM)Wtsi/Abca4tm1a(EUCOMM)Wtsi
(C57BL/6N-Abca4tm1a(EUCOMM)Wtsi/Wtsi)
decreased CD4-positive, alpha beta T cell number J:211773
vertebral fusion J:211773
Abca4tm1Ght/Abca4tm1Ght
(involves: 129S4/SvJae * C57BL/6)
abnormal Bruch membrane morphology J:56317
abnormal eye physiology J:56317
abnormal photoreceptor outer segment morphology J:56317
abnormal retinal pigment epithelium morphology J:56317
delayed dark adaptation J:56317
retinal photoreceptor degeneration J:56317
Abca4tm1Ght/Abca4tm1Ght
(involves: 129S4/SvJae)
abnormal eye physiology J:117483
abnormal retinal pigment epithelium morphology J:141801
abnormal vitamin A level J:141801
Abca4tm1Ght/Abca4tm1Ght
(involves: 129S4/SvJae * BALB/c)
abnormal retinal pigment epithelium morphology J:141801
photoreceptor outer segment degeneration J:141801
thin retinal outer nuclear layer J:141801
Abca4tm1Ght/Abca4tm1Ght
Rdh8tm1Kpal/Rdh8tm1Kpal

(involves: 129 * 129S4/SvJae)
abnormal Bruch membrane morphology J:154536
abnormal cone electrophysiology J:154536
abnormal eye electrophysiology J:154536
abnormal retinal photoreceptor morphology J:154536
abnormal retinal pigment epithelium morphology J:154536
abnormal retinal pigmentation J:154536
abnormal rod electrophysiology J:154536
decreased retinal cone cell number J:154536
decreased retinal photoreceptor cell number J:154536
retinal degeneration J:154536
retinal deposits J:154536
retinal neovascularization J:154536
thin retinal outer nuclear layer J:154536
Abca4tm1Kpal/Abca4tm1Kpal
Rdh8tm1Kpal/Rdh8tm1Kpal

(involves: 129)
abnormal eye morphology J:213619
Abca4tm2.1Kpal/Abca4tm2.1Kpal
(involves: 129 * 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * C57BL/6N)
lipofuscinosis J:221141
vision/eye phenotype J:221141
Abca4tm2.1Kpal/Abca4tm2.1Kpal
Gnat1tm1Clma/Gnat1tm1Clma

(involves: 129 * C57BL/6 * C57BL/6N)
abnormal cone electrophysiology J:221141
lipofuscinosis J:221141
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj)
abnormal cardiac thrombosis J:99152
abnormal liver physiology J:99152
abnormal thyroid follicle morphology J:99152
absent thyroid gland J:99152
decreased activity of thyroid gland J:99152
dilated cardiomyopathy J:99152
exophthalmos J:99152
myocardial fiber degeneration J:99152
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)
abnormal cardiac thrombosis J:99152
abnormal liver morphology J:99152
abnormal thyroid follicle morphology J:99152
absent thyroid gland J:99152
decreased activity of thyroid gland J:99152
dilated cardiomyopathy J:99152
edema J:99152
exophthalmos J:99152
myocardial fiber degeneration J:99152
premature death J:99152
tremors J:99152
visceral vascular congestion J:99152
Abca6tm2b(KOMP)Wtsi/Abca6tm2b(KOMP)Wtsi
(C57BL/6N-Abca6tm2b(KOMP)Wtsi/Tcp)
decreased circulating serum albumin level J:211773
decreased circulating total protein level J:211773
increased hematocrit J:211773
Abca7tm1Frm/Abca7tm1Frm
(involves: 129S4/SvJae * C57BL/6)
decreased circulating cholesterol level J:96865
decreased circulating HDL cholesterol level J:96865
decreased white adipose tissue amount J:96865
small kidney J:96865
Abca7tm2b(EUCOMM)Hmgu/Abca7tm2b(EUCOMM)Hmgu
(B6N(Cg)-Abca7tm2b(EUCOMM)Hmgu/J)
cardiovascular system phenotype J:211773
decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
increased heart rate variability J:211773
Abca8btm1a(EUCOMM)Wtsi/Abca8btm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
decreased circulating cholesterol level J:269226
decreased circulating HDL cholesterol level J:269226
decreased circulating LDL cholesterol level J:269226
decreased circulating triglyceride level J:269226
Abca8btm1b(EUCOMM)Wtsi/Abca8btm1b(EUCOMM)Wtsi
(C57BL/6N-Abca8btm1b(EUCOMM)Wtsi/Ucd)
abnormal eye morphology J:211773
Abca9em1(IMPC)J/Abca9em1(IMPC)J
(C57BL/6NJ-Abca9em1(IMPC)J/J)
abnormal behavioral response to light J:211773
Abca12el12/Abca12+
(involves: 129/Sv * C57BL/6)
abnormal lipid homeostasis J:161652
decreased cholesterol efflux J:161652
Abca12el12/Abca12el12
(involves: 129/Sv * C57BL/6)
abnormal corneocyte envelope morphology J:161652
abnormal epidermal lamellar body morphology J:161652
abnormal epidermis stratum basale morphology J:161652
abnormal lipid homeostasis J:161652
abnormal skin development J:161652
abnormal skin morphology J:161652
absent suckling reflex J:161652
decreased cholesterol efflux J:161652
decreased fetal size J:161652
dehydration J:161652
hyperkeratosis J:161652
impaired skin barrier function J:161652
increased cholesterol level J:161652
neonatal lethality, complete penetrance J:161652
thick epidermis stratum granulosum J:161652
thin epidermis J:161652
thin epidermis stratum spinosum J:161652
tight skin J:161652
Abca12smsk/Abca12smsk
(involves: C57BL/6J)
abnormal epidermal lamellar body morphology J:262458
abnormal epidermis stratum basale morphology J:262458
abnormal epidermis stratum corneum morphology J:262458
abnormal keratinocyte physiology J:262458
abnormal skin development J:262458
dehydration J:262458
dry skin J:262458
hyperkeratosis J:262458
impaired skin barrier function J:262458
impaired stratum corneum desquamation J:262458
parakeratosis J:262458
perinatal lethality, complete penetrance J:262458
shiny skin J:262458
thick epidermis stratum granulosum J:262458
thin epidermis stratum spinosum J:262458
tight skin J:262458
translucent skin J:262458
Abca12tm1Lex/Abca12tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
preweaning lethality, complete penetrance J:103485
Abca12tm1Lex/Abca12tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J)
abnormal epidermal lamellar body morphology J:144062
abnormal lipid homeostasis J:144062
epidermal desquamation J:144062
hyperkeratosis J:144062
impaired skin barrier function J:144062
neonatal lethality, complete penetrance J:144062
parakeratosis J:144062
Abca12tm1Shzu/Abca12tm1Shzu
(B6.129S-Abca12tm1Shzu)
abnormal epidermal lamellar body morphology J:139048
abnormal epidermal layer morphology J:139048
abnormal pulmonary alveolus morphology J:139048
abnormal skin condition J:139048
abnormal skin development J:139048
abnormal surfactant secretion J:139048
abnormal type II pneumocyte morphology J:139048
absent alveolar lamellar bodies J:139048
atelectasis J:139048
decreased birth weight J:139048
decreased fetal weight J:139048
dehydration J:139048
eclabion J:139048
hyperkeratosis J:139048
impaired skin barrier function J:139048
neonatal lethality, complete penetrance J:139048
pulmonary vascular congestion J:139048
reddish skin J:139048
scaly skin J:139048
shiny skin J:139048
skin lesions J:139048
thick pulmonary interalveolar septum J:139048
tight skin J:139048
Abca13tm1b(EUCOMM)Wtsi/Abca13tm1b(EUCOMM)Wtsi
(C57BL/6N-Abca13tm1b(EUCOMM)Wtsi/Bay)
abnormal male genitalia morphology J:211773
decreased blood urea nitrogen level J:211773
decreased mean corpuscular volume J:211773
increased mean corpuscular volume J:211773
Abca14tm1.1(NCOM)Mfgc/Abca14tm1.1(NCOM)Mfgc
(C57BL/6N-Abca14tm1.1(NCOM)Mfgc/Tcp)
decreased total body fat amount J:211773
Abca17tm1b(EUCOMM)Wtsi/Abca17tm1b(EUCOMM)Wtsi
(C57BL/6N-Abca17tm1b(EUCOMM)Wtsi/Bay)
decreased circulating potassium level J:211773
Abcb1amds/Abcb1amds
(involves: CF-1)
abnormal hippocampus CA3 region morphology J:64725
catalepsy J:64725
hippocampal neuron degeneration J:64725
increased eosinophil cell number J:64725
increased physiological sensitivity to xenobiotic J:40292, J:64725
premature death J:64725
tremors J:64725
Abcb1atm1.1Kane/Abcb1a+
(involves: 129S1/SvImJ)
no phenotypic analysis J:147139
Abcb1atm1Bor/Abcb1atm1Bor
(involves: 129P2/OlaHsd * FVB)
abnormal blood-brain barrier function J:18554
abnormal xenobiotic pharmacokinetics J:39804
increased physiological sensitivity to xenobiotic J:18554
Abcb1atm1Bor/Abcb1atm1Bor
(FVBTac.129P2-Abcb1atm1Bor)
abnormal blood-inner ear barrier function J:59145
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology J:102640
abnormal xenobiotic pharmacokinetics J:59145, J:102640
decreased gamma-delta intraepithelial T cell number J:102640
increased physiological sensitivity to xenobiotic J:59145
increased susceptibility to ototoxicity-induced hearing loss J:59145
Abcb1atm1Bor/Abcb1atm1Bor
(FVB.129P2-Abcb1atm1Bor/TacImx)
abnormal intestinal epithelium morphology J:51190
abnormal intestinal mucosa morphology J:51190
abnormal large intestine crypts of Lieberkuhn morphology J:51190
abnormal lymphocyte physiology J:51190
cachexia J:51190
colitis J:51190
crypts of Lieberkuhn abscesses J:51190
increased IgA level J:51190
increased IgE level J:51190
increased IgG1 level J:51190
increased IgG2 level J:51190
increased IgG2a level J:51190
increased IgG2b level J:51190
increased IgG3 level J:51190
increased IgM level J:51190
increased immunoglobulin level J:51190
intestinal ulcer J:51190
large intestinal inflammation J:51190
mucous diarrhea J:51190
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor

(involves: 129P2/OlaHsd * FVB)
abnormal xenobiotic pharmacokinetics J:39804
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor

(FVBTac.129P2-Abcb1btm1Bor Abcb1atm1Bor)
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology J:102640
abnormal T cell physiology J:102640
abnormal xenobiotic pharmacokinetics J:102640, J:107822
decreased gamma-delta intraepithelial T cell number J:102640
increased double-positive T cell number J:102640
increased interferon-gamma secretion J:102640
increased interleukin-2 secretion J:102640
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor
Abcc2tm1Ahs/Abcc2tm1Ahs

(FVB.129P2-Abcb1btm1Bor Abcb1atm1Bor Abcc2tm1Ahs)
abnormal xenobiotic pharmacokinetics J:107822
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor
Tg(Thy1-AppDutch)#Jckr/0

(FVB.Cg-Abcb1btm1Bor Abcb1atm1Bor Tg(Thy1-AppDutch)#Jckr)
amyloid beta deposits J:178230
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor
Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr/0

(FVB.Cg-Abcb1btm1Bor Abcb1atm1Bor Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr)
amyloid beta deposits J:178230
Abcb1atm1Bor/Abcb1atm1Bor
Npc1m1N/Npc1m1N

(involves: 129/Ola * BALB/c)
abnormal maternal nurturing J:76395
abnormal motor capabilities/coordination/movement J:76395
increased liver cholesterol level J:76395
reproductive system phenotype J:76395
Abcb1atm1Kane/Abcb1a+
(involves: 129S1/SvImJ)
no phenotypic analysis J:147139
Abcb1btm2Bor/Abcb1btm2Bor
(involves: 129P2/OlaHsd * FVB)
abnormal xenobiotic pharmacokinetics J:39804
Abcb4tm1Bor/Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N))
abnormal bile canaliculus morphology J:21232, J:15531
abnormal bile composition J:15531
abnormal bile duct morphology J:15531
abnormal bile secretion J:15531
abnormal blood homeostasis J:15531
abnormal circulating alanine transaminase level J:15531
abnormal circulating alkaline phosphatase level J:15531
abnormal circulating aspartate transaminase level J:15531
abnormal circulating bilirubin level J:15531
abnormal hepatobiliary system morphology J:21232
abnormal hepatobiliary system physiology J:21232
abnormal hepatocyte morphology J:15531
abnormal portal triad morphology J:21232
bile duct inflammation J:21232, J:15531
bile duct proliferation J:21232
biliary cirrhosis J:21232
cholestasis J:21232
dilated bile duct J:15531
enlarged liver J:21232
hepatic necrosis J:21232
increased hepatocellular carcinoma incidence J:21232
intrahepatic cholestasis J:15531
liver hemorrhage J:21232
liver inflammation J:15531
reduced female fertility J:21232
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * FVB/N)
abnormal circulating enzyme level J:114411
abnormal feces composition J:175015
abnormal hepatocyte morphology J:175015
abnormal intestine physiology J:175015
abnormal lipid homeostasis J:114411
abnormal sodium ion homeostasis J:175015
bile duct inflammation J:175015
decreased circulating cholesterol level J:114411
decreased intestinal cholesterol absorption J:114411
focal hepatic necrosis J:175015
increased bile salt level J:175015
increased circulating alanine transaminase level J:175015, J:114411
increased circulating aspartate transaminase level J:114411
increased circulating bilirubin level J:114411
intrahepatic cholestasis J:175015
liver inflammation J:175015
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J)
abnormal bile composition J:105357, J:100491
abnormal bile duct morphology J:105357
abnormal circulating enzyme level J:105357
abnormal feces composition J:100491
abnormal gallbladder size J:105357
abnormal liver morphology J:105357
bile duct inflammation J:105357
dilated bile duct J:105357
enlarged liver J:105357
enlarged spleen J:217802
gallstones J:105357
homeostasis/metabolism phenotype J:100491
increased circulating alanine transaminase level J:217802, J:100491
increased circulating alkaline phosphatase level J:217802, J:105357
increased circulating aspartate transaminase level J:217802, J:100491
increased circulating bilirubin level J:217802, J:105357
increased hepatocellular carcinoma incidence J:217802
intrahepatic cholestasis J:105357
liver cirrhosis J:217802
liver fibrosis J:217802
portal hypertension J:217802
Abcb4tm1Bor/Abcb4tm1Bor
(C.129P2-Abcb4tm1Bor)
abnormal bone remodeling J:199949
abnormal compact bone morphology J:199949
abnormal enzyme/coenzyme activity J:199949
abnormal trabecular bone morphology J:199949
abnormal trabecular bone volume J:199949
decreased bone mineral content J:199949
decreased bone mineral density J:199949
decreased bone trabecula number J:199949
decreased bone volume J:199949
decreased circulating calcium level J:199949
decreased trabecular bone connectivity density J:199949
decreased vitamin D level J:199949
increased alkaline phosphatase activity J:199949
increased circulating phosphate level J:199949
increased transforming growth factor level J:199949
liver fibrosis J:199949
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * BALB/c)
bile duct inflammation J:168123
decreased systemic arterial systolic blood pressure J:168123
liver fibrosis J:168123
Abcb4tm1Bor/Abcb4tm1Bor
(CAnNCrl.12P2(FVB)-Abcb4tm1Bor)
enlarged spleen J:217802
increased circulating alanine transaminase level J:217802
increased circulating alkaline phosphatase level J:217802
increased circulating aspartate transaminase level J:217802
increased circulating bilirubin level J:217802
increased hepatocellular carcinoma incidence J:217802
liver cirrhosis J:217802
liver fibrosis J:217802
portal hypertension J:217802
weight loss J:217802
Abcb4tm1Bor/Abcb4tm1Bor
Pemttm1J/Pemttm1J

(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
abnormal feces composition J:175015
abnormal intestine physiology J:175015
decreased bile salt level J:175015
decreased circulating alanine transaminase level J:175015
liver/biliary system phenotype J:175015
Abcb4tm1Bor/Abcb4tm1Bor
Portm1Wolf/Portm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * C57BL/6 * DBA * FVB/N)
abnormal bile salt homeostasis J:215915
bile duct proliferation J:215915
cholestasis J:215915
growth/size/body region phenotype J:215915
increased bile salt level J:215915
increased circulating alanine transaminase level J:215915
increased circulating alkaline phosphatase level J:215915
increased circulating bilirubin level J:215915
increased hepatocyte proliferation J:215915
increased liver weight J:215915
liver fibrosis J:215915
Abcb4tm1Bor/Abcb4tm1Bor
Tg(ABCG5/ABCG8)14-2Hobb/0

(involves: 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)
abnormal bile composition J:100491
abnormal feces composition J:100491
decreased intestinal cholesterol absorption J:100491
homeostasis/metabolism phenotype J:100491
increased circulating alanine transaminase level J:100491
increased circulating aspartate transaminase level J:100491
Abcb5tm1.2Nyf/Abcb5tm1.2Nyf
(involves: 129S6/SvEvTac * C57BL/6)
abnormal cornea morphology J:213708
abnormal corneal epithelium morphology J:213708
abnormal corneal wound healing J:213708
abnormal eye physiology J:213708
abnormal photoreceptor inner segment morphology J:213708
abnormal photoreceptor outer segment morphology J:213708
abnormal retina morphology J:213708
abnormal retinal outer nuclear layer morphology J:213708
abnormal retinal pigment epithelium morphology J:213708
corneal epithelium hypoplasia J:213708
increased cell proliferation J:213708
Abcb6tm1a(KOMP)Wtsi/Abcb6tm1a(KOMP)Wtsi
(C57BL/6N-Abcb6tm1a(KOMP)Wtsi/Wtsi)
abnormal vibrissa morphology J:211773
decreased circulating alkaline phosphatase level J:211773
Abcb6tm1Jsch/Abcb6tm1Jsch
(involves: 129)
abnormal erythrocyte physiology J:184574
abnormal erythropoiesis J:184574
abnormal mitochondrial physiology J:184574
increased physiological sensitivity to xenobiotic J:184574
increased sensitivity to xenobiotic induced morbidity/mortality J:184574
lethality, incomplete penetrance J:184574
Abcb6tm1Pkr/Abcb6tm1Pkr
(involves: C57BL/6)
decreased physiological sensitivity to xenobiotic J:190243
Abcb7tm1.1Mdf/Y
(involves: 129S4/SvJae * FVB)
prenatal lethality J:106838
Abcb7tm1.1Mdf/Abcb7+
(involves: 129S4/SvJae * FVB)
genetic imprinting J:106838
prenatal lethality J:106838
Abcb7tm1Mdf/Y
Edil3Tg(Sox2-cre)1Amc/Edil3+

(either: B6.Cg-Edil3Tg(Sox2-cre)1Amc Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA))
embryonic lethality between somite formation and embryo turning, complete penetrance J:106838
Abcb7tm1Mdf/Y
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(either: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA))
abnormal circulating enzyme level J:106838
abnormal enzyme/coenzyme activity J:106838
abnormal hepatocyte morphology J:106838
abnormal liver morphology J:106838
hemosiderosis J:106838
Abcb7tm1Mdf/Y
Tg(Gata1-cre)1Sho/0

(either: (involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) or (involves: 129S4/SvJae * C57BL/6J * FVB/N))
abnormal ectoplacental cone morphology J:106838
embryonic growth retardation J:106838
embryonic lethality between implantation and somite formation, complete penetrance J:106838
hemorrhage J:106838
Abcb7tm1Mdf/Y
Tg(Nes-cre)1Kln/0

(either: B6.Cg-Tg(Nes-cre)1Kln Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL))
neonatal lethality, incomplete penetrance J:106838
nervous system phenotype J:106838
postnatal lethality, complete penetrance J:106838
Abcb7tm1Mdf/Y
Tg(Vil1-cre)20Syr/0

(either: (involves: 129S4/SvJae * C57BL/6 * DBA/2) or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2))
prenatal lethality, complete penetrance J:106838
Abcb7tm1Mdf/Abcb7+
Edil3Tg(Sox2-cre)1Amc/Edil3+

(either: B6.Cg-Edil3Tg(Sox2-cre)1Amc Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA))
mortality/aging J:106838
Abcb7tm1Mdf/Abcb7+
Tg(Gata1-cre)1Sho/0

(either: (involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N) or (involves: 129S4/SvJae * C57BL/6J * FVB/N))
abnormal ectoplacental cone morphology J:106838
embryonic growth retardation J:106838
embryonic lethality between implantation and somite formation, complete penetrance J:106838
hemorrhage J:106838
Abcb7tm1Mdf/Abcb7+
Tg(Vil1-cre)20Syr/0

(either: (involves: 129S4/SvJae * C57BL/6 * DBA/2) or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2))
prenatal lethality, complete penetrance J:106838
Abcb8tm1Hard/Abcb8tm1Hard
A1cfTg(Myh6-cre/Esr1*)1Jmk/0

(involves: FVB)
abnormal cardiac muscle relaxation J:182234
abnormal cardiovascular system physiology J:182234
abnormal heart morphology J:182234
abnormal myocardial fiber morphology J:182234
cardiac fibrosis J:182234
cardiomyopathy J:182234
decreased cardiac muscle contractility J:182234
decreased cardiac output J:182234
decreased left ventricle systolic pressure J:182234
increased heart iron level J:182234
increased heart left ventricle size J:182234
increased heart weight J:182234
Abcb9tm1b(KOMP)Wtsi/Abcb9tm1b(KOMP)Wtsi
(C57BL/6N-Abcb9tm1b(KOMP)Wtsi/Tcp)
small adrenal glands J:211773
Abcb10tm1.1Tafu/Abcb10tm1.2Tafu
Tg(Mx1-cre)1Cgn/0

(involves: C57BL/6J * C57BL/6NCrlj * CBA/J * CBA/JNCrlJ)
abnormal erythropoiesis J:223428
abnormal hemoglobin J:223428
abnormal iron level J:223428
abnormal mitochondrion morphology J:223428
decreased erythrocyte cell number J:223428
decreased hemoglobin content J:223428
decreased mean corpuscular hemoglobin concentration J:223428
decreased mean corpuscular volume J:223428
hypochromic microcytic anemia J:223428
reticulocytosis J:223428
Abcb10tm1.2Tafu/Abcb10tm1.2Tafu
(involves: C57BL/6NCrlj * CBA/JNCrlj)
abnormal blood cell morphology J:223428
abnormal embryonic hematopoiesis J:223428
abnormal hemoglobin J:223428
abnormal hepatocyte morphology J:223428
abnormal iron level J:223428
abnormal liver morphology J:223428
abnormal liver physiology J:223428
embryonic lethality during organogenesis, complete penetrance J:223428
oxidative stress J:223428
pallor J:223428
Abcb10tm1Lex/Abcb10+
(involves: 129S/SvEvBrd * C57BL/6)
abnormal mitochondrial physiology J:189396
cardiovascular system phenotype J:189396
decreased systemic arterial systolic blood pressure J:189396
increased response of heart to induced stress J:189396
increased systemic arterial diastolic blood pressure J:189396
oxidative stress J:189396
Abcb10tm1Lex/Abcb10tm1Lex
(involves: 129S/SvEvBrd * C57BL/6)
embryonic lethality, complete penetrance J:189396
Abcb11tm1a(EUCOMM)Hmgu/Abcb11tm1a(EUCOMM)Hmgu
(C57BL/6N-Abcb11tm1a(EUCOMM)Hmgu/Ieg)
abnormal retina morphology J:165965
increased circulating alanine transaminase level J:165965
increased circulating alkaline phosphatase level J:165965
increased circulating aspartate transaminase level J:165965
increased circulating potassium level J:165965
increased lean body mass J:165965
Abcb11tm1b(EUCOMM)Hmgu/Abcb11+
(C57BL/6N-Abcb11tm1b(EUCOMM)Hmgu/Ieg)
abnormal behavior J:211773
abnormal lung morphology J:211773
Abcb11tm1b(EUCOMM)Hmgu/Abcb11tm1b(EUCOMM)Hmgu
(C57BL/6N-Abcb11tm1b(EUCOMM)Hmgu/Ieg)
preweaning lethality, incomplete penetrance J:211773
Abcb11tm1Wng/Abcb11tm1Wng
(involves: 129S6/SvEvTac * C57BL/6J)
abnormal bile canaliculus morphology J:67548
abnormal bile salt level J:67548
abnormal bile secretion J:67548
abnormal hepatocyte morphology J:67548
abnormal phospholipid level J:67548
decreased body weight J:67548
decreased glycogen level J:67548
enlarged liver J:67548
increased bile salt level J:67548
increased cholesterol level J:67548
intrahepatic cholestasis J:67548
postnatal growth retardation J:67548
Abcc1tm1Acs/Abcc1tm1Acs
(involves: 129S1/Sv * C57BL/6)
abnormal homeostasis J:44305
hematopoietic system phenotype J:44305
increased physiological sensitivity to xenobiotic J:44305
Abcc1tm1Bor/Abcc1tm1Bor
(involves: 129P2/OlaHsd * FVB)
abnormal mast cell physiology J:44110
decreased inflammatory response J:44110
increased physiological sensitivity to xenobiotic J:44110
increased sensitivity to xenobiotic induced morbidity/mortality J:44110
mortality/aging J:44110
Abcc1tm1Bor/Abcc1tm1Bor
Tg(Thy1-AppDutch)#Jckr/0

(FVB.Cg-Abcc1tm1Bor Tg(Thy1-AppDutch)#Jckr)
abnormal homeostasis J:178230
amyloid beta deposits J:178230
Abcc1tm1Bor/Abcc1tm1Bor
Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr/0

(FVB.Cg-Abcc1tm1Bor Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr)
amyloid beta deposits J:178230
microgliosis J:178230
Abcc2tm1.1(ABCC2)Arte/Abcc2tm1.1(ABCC2)Arte
(C57BL/6-Abcc2tm1.1(ABCC2)Arte)
homeostasis/metabolism phenotype J:208127
Abcc2tm1.1(ABCC2)Arte/Abcc2tm1.1(ABCC2)Arte
Nr1i2tm1(NR1I2)Arte/Nr1i2tm1(NR1I2)Arte

(involves: C57BL/6)
homeostasis/metabolism phenotype J:216646
Abcc2tm1Ahs/Abcc2tm1Ahs
(involves: 129P2/OlaHsd * FVB)
abnormal bile secretion J:107822
abnormal blood homeostasis J:107822
abnormal kidney physiology J:107822
abnormal liver physiology J:107822
abnormal xenobiotic pharmacokinetics J:107822
bilirubinuria J:107822
decreased hemoglobin content J:107822
increased circulating bilirubin level J:107822
increased liver weight J:107822
Abcc2tm1Ahs/Abcc2tm1Ahs
(FVB.129P2-Abcc2tm1Ahs)
abnormal xenobiotic pharmacokinetics J:107822
bilirubinuria J:216646
increased circulating bilirubin level J:216646
Abcc2tm1Ahs/Abcc2tm1Ahs
(B6.129P2(FVB)-Abcc2tm1Ahs)
increased circulating bilirubin level J:208127
increased physiological sensitivity to xenobiotic J:208127
Abcc2tm1Dgen/Abcc2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
abnormal bile composition J:134950
abnormal bile secretion J:134950
abnormal liver physiology J:134950
decreased circulating alkaline phosphatase level J:134950
increased circulating bilirubin level J:134950
increased circulating cholesterol level J:134950
Abcc2tm2b(KOMP)Wtsi/Abcc2tm2b(KOMP)Wtsi
(C57BL/6N-Abcc2tm2b(KOMP)Wtsi/H)
decreased mean corpuscular hemoglobin J:211773
decreased mean corpuscular volume J:211773
decreased mean platelet volume J:211773
increased circulating bilirubin level J:211773
increased kidney weight J:211773
Abcc3tm1Bor/Abcc3tm1Bor
(involves: 129P2/Ola * FVB/N)
abnormal bile salt homeostasis J:149653
abnormal xenobiotic pharmacokinetics J:99234
Abcc3tm1Bor/Abcc3tm1Bor
(FVB.129P2-Abcc3tm1Bor)
abnormal xenobiotic pharmacokinetics J:99234
decreased chemically-elicited antinociception J:99234
Abcc3tm1Kruh/Abcc3tm1Kruh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal bile salt level J:114229
increased circulating bilirubin level J:114229
liver/biliary system phenotype J:114229
Abcc3tm1Kruh/Abcc3tm1Kruh
Slc51atm1Pda/Slc51atm1Pda

(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
abnormal bile salt homeostasis J:132778
Abcc4Gt(RRC212)Byg/Abcc4Gt(RRC212)Byg
(involves: 129P2/OlaHsd * C57BL/6)
decreased prostaglandin level J:139829
increased chemical nociceptive threshold J:139829
increased thermal nociceptive threshold J:139829
Abcc4tm1Jsch/Abcc4tm1Jsch
(involves: 129X1/SvJ)
abnormal blood-brain barrier function J:92788
abnormal blood-cerebrospinal fluid barrier function J:92788
abnormal urine organic anion level J:92788
Abcc4tm1Kruh/Abcc4tm1Kruh
(B6.129-Abcc4tm1Kruh)
abnormal blood homeostasis J:117326
abnormal blood-brain barrier function J:117326
abnormal intestinal mucosa morphology J:117326
abnormal small intestine morphology J:117326
abnormal spleen B cell follicle morphology J:117326
abnormal spleen red pulp morphology J:117326
increased sensitivity to induced morbidity/mortality J:117326
increased susceptibility to induced colitis J:117326
intestinal inflammation J:117326
small intestinal inflammation J:117326
small spleen J:117326
thymus cortex hypoplasia J:117326
weight loss J:117326
Abcc5em1(IMPC)H/Abcc5em1(IMPC)H
(C57BL/6N-Abcc5em1(IMPC)H/H)
decreased circulating glucose level J:211773
decreased eosinophil cell number J:211773
decreased leukocyte cell number J:211773
decreased lymphocyte cell number J:211773
limb grasping J:211773
Abcc5tm1Bor/Abcc5tm1Bor
(involves: 129P2/OlaHsd * FVB)
cellular phenotype J:135561
Abcc6Dyscalc1-C3H/DiSnA/Abcc6Dyscalc1-C57BL/10
(involves: C3H/DiSnA * C57BL/10)
decreased susceptibility to dystrophic cardiac calcinosis J:76777
Abcc6Dyscalc1-C3H/HeNCrl/Abcc6Dyscalc1-C3H/HeNCrl
(involves: C3H/HeNCrl * C57BL/6NCrl)
increased susceptibility to dystrophic cardiac calcinosis J:109580
Abcc6Dyscalc1-C57BL/6J/Abcc6Dyscalc1-C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
decreased susceptibility to dystrophic cardiac calcinosis J:72021
Abcc6Dyscalc1-C57BL/10/Abcc6Dyscalc1-C57BL/10
(involves: C3H/DiSnA * C57BL/10)
decreased susceptibility to dystrophic cardiac calcinosis J:76777
Abcc6Dyscalc1-DBA/2J/Abcc6Dyscalc1-DBA/2J
(involves: C57BL/6J * DBA/2J)
increased susceptibility to dystrophic cardiac calcinosis J:76777
Abcc6rs32756904-T/Abcc6Dyscalc1-C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
decreased susceptibility to dystrophic cardiac calcinosis J:72021
Abcc6rs32756904-T/Abcc6rs32756904-T
(involves: C3H/HeJ * C57BL/6J)
increased susceptibility to dystrophic cardiac calcinosis J:72021, J:33253
Abcc6rs32756904-T/Abcc6rs32756904-T
Dyscalc2C3H/HeJ/?

(involves: C3H/HeJ * C57BL/6J)
increased susceptibility to dystrophic cardiac calcinosis J:72021
Abcc6tm1Aabb/Abcc6tm1Aabb
(involves: 129P2/OlaHsd * C57BL/6)
abnormal Bruch membrane morphology J:105062
abnormal kidney blood vessel morphology J:105062
calcified artery J:105062
calcified skin J:105062
decreased circulating HDL cholesterol level J:105062
increased circulating creatinine level J:105062
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
E2f1Tg(Wnt1-cre)2Sor/?

(B6.Cg-E2f1Tg(Wnt1-cre)2Sor Abcc6tm1c(EUCOMM)Wtsi)
abnormal snout skin morphology J:252837
calcified skin J:252837
calcinosis J:252837
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
E2f1Tg(Wnt1-cre)2Sor/?
Speer6-ps1Tg(Alb-cre)21Mgn/?

(B6.Cg-E2f1Tg(Wnt1-cre)2Sor Abcc6tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn)
abnormal snout skin morphology J:252837
calcified skin J:252837
calcinosis J:252837
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
Pax7tm1(cre)Mrc/?

(B6.Cg-Pax7tm1(cre)Mrc Abcc6tm1c(EUCOMM)Wtsi)
integument phenotype J:252837
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
Ptprctm1(cre)Medv/?

(B6.Cg-Ptprctm1(cre)Medv Abcc6tm1c(EUCOMM)Wtsi)
integument phenotype J:252837
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/?

(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn)
abnormal snout skin morphology J:252837
calcified skin J:252837
calcinosis J:252837
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/?
Tg(Cdx1-cre)23Kem/?

(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn Tg(Cdx1-cre)23Kem)
abnormal snout skin morphology J:252837
calcified skin J:252837
calcinosis J:252837
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
Tg(Cdh5-cre)7Mlia/?

(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Tg(Cdh5-cre)7Mlia)
integument phenotype J:252837
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
Tg(Cdh16-cre)91Igr/?

(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Tg(Cdh16-cre)91Igr)
integument phenotype J:252837
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
Tg(CMV-cre)1Cgn/?

(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Tg(CMV-cre)1Cgn)
abnormal snout skin morphology J:252837
calcified skin J:252837
calcinosis J:252837
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
Tg(Fabp4-cre)1Rev/?

(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Tg(Fabp4-cre)1Rev)
integument phenotype J:252837
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
Tg(Pdgfrb-cre)35Vli/?

(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Tg(Pdgfrb-cre)35Vli)
integument phenotype J:252837
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
Tg(Tagln-cre)1Her/?

(B6.Cg-Abcc6tm1c(EUCOMM)Wtsi Tg(Tagln-cre)1Her)
integument phenotype J:252837
Abcc6tm1Jfk/Abcc6tm1Jfk
(involves: 129S1/Sv * C57BL/6J)
abnormal vibrissa follicle morphology J:101372
calcified artery J:101372
calcified retina J:101372
calcified skin J:101372
calcinosis J:101372
nephrocalcinosis J:101372
Abcc6tm1Jfk/Abcc6tm1Jfk
(B6.129S1-Abcc6tm1Jfk)
abnormal snout skin morphology J:252837
calcified skin J:252837
calcinosis J:252837
Abcc6tm1Jfk/Abcc6tm1Jfk
Enpp1asj/Enpp1+

(B6.Cg-Abcc6tm1Jfk Enpp1asj)
abnormal snout skin morphology J:252837
calcified skin J:252837
calcinosis J:252837
Abcc6tm1Jfk/Abcc6tm1Jfk
Enpp1asj/Enpp1asj

(B6.Cg-Abcc6tm1Jfk Enpp1asj)
abnormal snout skin morphology J:252837
calcified skin J:252837
calcinosis J:252837
Abcc6tm1Jfk/Abcc6tm1Jfk
Nt5etm1Lft/Nt5etm1Lft

(B6.Cg-Abcc6tm1Jfk Nt5etm1Lft)
abnormal snout skin morphology J:252837
calcified skin J:252837
calcinosis J:252837
Abcc6tm1Jfk/Abcc6tm1Jfk
Samd9ltm1Homy/Samd9ltm1Homy

(B6.129-Samd9ltm1Homy Abcc6tm1Jfk)
abnormal vibrissa morphology J:225110
calcinosis J:225110
Abcc8tm1.1Fmas/Abcc8+
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
abnormal pancreatic beta cell morphology J:208932
Abcc8tm1.1Fmas/Abcc8tm1.1Fmas
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
abnormal pancreatic beta cell morphology J:208932
decreased circulating glucose level J:208932
decreased insulin secretion J:208932
homeostasis/metabolism phenotype J:208932
impaired glucose tolerance J:208932
increased circulating glucose level J:208932
increased insulin secretion J:208932
Abcc8tm1.1Mgn/Abcc8tm1.1Mgn
(involves: 129X1/SvJ * C57BL/6)
decreased insulin secretion J:79352
hypoglycemia J:79352
impaired glucose tolerance J:79352
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ * C57BL/6)
hypoglycemia J:61356
impaired glucose tolerance J:61356
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ)
abnormal insulin secretion J:179577
decreased circulating glucose level J:179577
decreased insulin secretion J:179577
increased circulating glucose level J:179577
Abcc8tm1Jbry/Abcc8tm1Jbry
Sstr5tm1Fcb/Sstr5tm1Fcb

(involves: 129X1/SvJ)
abnormal insulin secretion J:179577
decreased circulating glucose level J:179577
decreased insulin secretion J:179577
increased circulating glucose level J:179577
Abcc8tm1Mgn/Abcc8+
(involves: 129X1/SvJ)
no phenotypic analysis J:79352
Abcc9tm1.1Mcn/Abcc9tm1.1Mcn
Tg(Tagln-cre)1Her/0

(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal fetal cardiomyocyte morphology J:216539
abnormal fetal cardiomyocyte physiology J:216539
abnormal mitochondrial physiology J:216539
abnormal mitochondrion morphology J:216539
cardiomyopathy J:216539
decreased cardiac muscle contractility J:216539
decreased fatty acid oxidation J:216539
decreased mitochondria size J:216539
decreased oxygen consumption J:216539
enlarged heart J:216539
homeostasis/metabolism phenotype J:216539
hypoxia J:216539
increased cellular sensitivity to hydrogen peroxide J:216539
increased heart weight J:216539
oxidative stress J:216539
postnatal lethality, complete penetrance J:216539
Abcc9tm1Cfb/Abcc9tm1Cfb
(involves: CD-1)
hypoglycemia J:71840
improved glucose tolerance J:71840
increased insulin sensitivity J:71840
increased muscle cell glucose uptake J:71840
premature death J:71840
slow postnatal weight gain J:71840
Abcc9tm1Cfb/Abcc9tm1Cfb
(Not Specified)
abnormal ST segment J:78066
abnormal systemic arterial blood pressure J:78066
abnormal vascular smooth muscle physiology J:78066
abnormal vasoconstriction J:78066
artery stenosis J:78066
hypertension J:78066
increased systemic arterial diastolic blood pressure J:78066
increased systemic arterial systolic blood pressure J:78066
premature death J:78066
Abcc10tm1Eah/Abcc10tm1Eah
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal spleen red pulp morphology J:172648
decreased body weight J:172648
decreased bone marrow cell number J:172648
decreased leukocyte cell number J:172648
decreased spleen germinal center number J:172648
decreased spleen germinal center size J:172648
decreased spleen white pulp amount J:172648
increased physiological sensitivity to xenobiotic J:172648
increased sensitivity to induced morbidity/mortality J:172648
small spleen J:172648
thymus cortex hypoplasia J:172648
Abcc12tm1Bor/Abcc12+
(Not Specified)
no phenotypic analysis J:125562
Abcd1tm1a(EUCOMM)Wtsi/Y
(B6JTyr;B6N-Abcd1tm1a(EUCOMM)Wtsi/Wtsi)
abnormal lens morphology J:165965
cataract J:165965
no abnormal phenotype detected J:213427
Abcd1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal lipid homeostasis J:44812
reduced fertility J:44812
Abcd1tm1Kan/Y
(involves: 129 * BALB/cJ * C57BL/6J * Swiss)
increased fatty acid level J:257393
Abcd1tm1Kan/Y
Gt(ROSA)26Sortm2.1(CAG-ELOVL1)Geno/Gt(ROSA)26Sor+
Cnptm1(cre)Kan/Cnp+

(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)
increased fatty acid level J:257393
Abcd1tm1Kan/Y
Gt(ROSA)26Sortm2.1(CAG-ELOVL1)Geno/Gt(ROSA)26Sor+
Tg(CMV-cre)1Cgn/0

(involves: 129 * BALB/cJ * C57BL/6J * Swiss)
increased fatty acid level J:257393
lethality, incomplete penetrance J:257393
Abcd1tm1Kan/Abcd1tm1Kan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal lipid homeostasis J:44812
reduced fertility J:44812
Abcd1tm1Kds/Y
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))
abnormal lipid homeostasis J:42479
increased saturated fatty acid level J:42479
Abcd1tm1Kds/Y
(involves: 129S4/SvJae * C57BL/6J)
abnormal adrenal cortex morphology J:94583
abnormal adrenal gland zona fasciculata morphology J:94583
abnormal adrenal gland zona reticularis morphology J:94583
abnormal astrocyte morphology J:94583
abnormal locomotor activation J:94583
abnormal microglial cell morphology J:94583
abnormal myelination J:94583
abnormal nerve conduction J:94583
abnormal nervous system physiology J:94583
abnormal spinal cord morphology J:94583
astrocytosis J:94583
axon degeneration J:94583
impaired coordination J:94583
increased fatty acid level J:94583
Abcd1tm1Kds/Y
Abcd2tm1Apuj/Abcd2tm1Apuj

(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
abnormal adrenal cortex morphology J:94583
abnormal astrocyte morphology J:94583
abnormal CNS glial cell morphology J:104122
abnormal involuntary movement J:104122
abnormal locomotor activation J:94583
abnormal locomotor behavior J:104122
abnormal microglial cell morphology J:94583
abnormal nerve conduction J:94583
abnormal nervous system electrophysiology J:104122
abnormal nervous system physiology J:94583
abnormal posture J:104122
astrocytosis J:94583
ataxia J:104122
axon degeneration J:94583
decreased vertical activity J:104122
impaired balance J:104122
impaired coordination J:94583
increased fatty acid level J:94583, J:104122
increased inflammatory response J:94583
tremors J:104122
Abcd1tm1Kds/Y
Slc27a2tm1Kds/Slc27a2tm1Kds

(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J)
no abnormal phenotype detected J:83438
Abcd1tm1Kds/Abcd1tm1Kds
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))
abnormal lipid homeostasis J:42479
increased saturated fatty acid level J:42479
Abcd1tm1Kds/Abcd1tm1Kds
(involves: 129/Sv * 129S4/SvJae * C57BL/6J)
abnormal motor coordination/balance J:75388
abnormal myelination J:75388
abnormal nerve conduction J:75388
abnormal Schwann cell morphology J:75388
axon degeneration J:75388
decreased vertical activity J:75388
impaired coordination J:75388
Abcd1tm1Kds/Abcd1tm1Kds
Slc27a2tm1Kds/Slc27a2tm1Kds

(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J)
no abnormal phenotype detected J:83438
Abcd1tm1Ymd/Y
(involves: 129S/SvEv * C57BL/6J * DBA/2J)
abnormal lipid homeostasis J:40230
Abcd1tm1Ymd/Abcd1tm1Ymd
(involves: 129S/SvEv * C57BL/6J * DBA/2J)
abnormal lipid homeostasis J:40230
Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal astrocyte morphology J:94583
abnormal axon morphology J:104122
abnormal cerebellar Purkinje cell layer J:104122
abnormal CNS glial cell morphology J:104122
abnormal dorsal root ganglion morphology J:104122
abnormal locomotor behavior J:104122
abnormal microglial cell morphology J:94583
abnormal motor coordination/balance J:104122
abnormal nervous system electrophysiology J:104122
abnormal nervous system physiology J:104122
abnormal posture J:104122
abnormal Purkinje cell morphology J:104122
astrocytosis J:104122
ataxia J:104122
axon degeneration J:94583, J:104122
gliosis J:104122
hyperactivity J:104122
impaired balance J:104122
impaired coordination J:104122
increased fatty acid level J:94583, J:104122
neuron degeneration J:104122
Purkinje cell degeneration J:104122
tremors J:104122
Abcd3em1(IMPC)J/Abcd3em1(IMPC)J
(C57BL/6NJ-Abcd3em1(IMPC)J/J)
decreased bone mineral density J:211773
decreased grip strength J:211773
increased lean body mass J:211773
Abcd3tm1Safe/Abcd3tm1Safe
(involves: 129S4/SvJae * C57BL/6J)
abnormal bile composition J:217065
abnormal blood homeostasis J:217065
abnormal cell morphology J:217065
enlarged liver J:217065
Abcd4tm1a(EUCOMM)Hmgu/Abcd4tm1a(EUCOMM)Hmgu
(Not Specified)
abnormal response to new environment J:165965
abnormal response to tactile stimuli J:165965
Abce1Tg(Tyr)2295G-2b3Ove/Abce1Tg(Tyr)2295G-2b3Ove
(FVB/N-Abce1Tg(Tyr)2295G-2b3Ove)
embryonic lethality between implantation and somite formation, complete penetrance J:175597
Abce1tm1.1(KOMP)Vlcg/Abce1+
(C57BL/6N-Abce1tm1.1(KOMP)Vlcg/Tcp)
abnormal behavior J:211773
abnormal seminal vesicle morphology J:211773
decreased prepulse inhibition J:211773
enlarged lymph nodes J:211773
hyperactivity J:211773
Abce1tm1.1(KOMP)Vlcg/Abce1tm1.1(KOMP)Vlcg
(C57BL/6N-Abce1tm1.1(KOMP)Vlcg/Tcp)
preweaning lethality, complete penetrance J:211773
Abce1tm1b(EUCOMM)Hmgu/Abce1+
(C57BL/6N-Abce1tm1b(EUCOMM)Hmgu/H)
decreased circulating creatinine level J:211773
Abce1tm1b(EUCOMM)Hmgu/Abce1tm1b(EUCOMM)Hmgu
(C57BL/6N-Abce1tm1b(EUCOMM)Hmgu/H)
embryonic lethality prior to organogenesis J:211773
preweaning lethality, complete penetrance J:211773
Abcf1Gt(XK097)Byg/Abcf1Gt(XK097)Byg
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6))
embryonic lethality prior to organogenesis J:245222
Abcg1tm1Asch/Abcg1tm1Asch
(involves: 129X1/SvJ * C57BL/6)
abnormal brown adipose tissue morphology J:122438
abnormal fat cell morphology J:122438
decreased susceptibility to diet-induced obesity J:122438
decreased susceptibility to hepatic steatosis J:122438
hyperactivity J:122438
hypoglycemia J:122438
increased body temperature J:122438
increased energy expenditure J:122438
increased oxygen consumption J:122438
Abcg1tm1Dgen/Abcg1+
Abcg4tm1Dgen/Abcg4tm1Dgen

(involves: 129P2/OlaHsd)
abnormal lipid homeostasis J:141549
abnormal lipid level J:141549
decreased cholesterol efflux J:141549
Abcg1tm1Dgen/Abcg1tm1Dgen
(B6.129P2-Abcg1tm1Dgen)
abnormal lung morphology J:117028
abnormal macrophage physiology J:117028
abnormal phospholipid level J:117028
hepatic steatosis J:117028
increased cholesterol level J:117028
increased macrophage derived foam cell number J:117028
increased triglyceride level J:117028
renal/urinary system phenotype J:117028
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
abnormal chemokine secretion J:130777
abnormal cytokine secretion J:130777
abnormal leukocyte morphology J:132952
abnormal lung morphology J:132952
abnormal macrophage morphology J:132952
abnormal monocyte differentiation J:132952
abnormal surfactant secretion J:132952
decreased cholesterol efflux J:130777
increased B cell number J:132952
increased CD4-positive, alpha beta T cell number J:132952
increased CD8-positive, alpha-beta T cell number J:132952
increased dendritic cell number J:132952
increased eosinophil cell number J:132952
increased monocyte cell number J:132952
increased neutrophil cell number J:132952
lipidosis J:132952
lung inflammation J:132952
overexpanded pulmonary alveoli J:132952
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd)
abnormal lipid level J:141549
Abcg1tm1Dgen/Abcg1tm1Dgen
Abcg4tm1Dgen/Abcg4+

(involves: 129P2/OlaHsd)
abnormal lipid homeostasis J:141549
abnormal lipid level J:141549
decreased cholesterol efflux J:141549
Abcg1tm1Dgen/Abcg1tm1Dgen
Abcg4tm1Dgen/Abcg4tm1Dgen

(involves: 129P2/OlaHsd)
abnormal cholesterol homeostasis J:141549
abnormal lipid homeostasis J:141549
abnormal lipid level J:141549
decreased cholesterol efflux J:141549
Abcg1tm1Yah/Abcg1+
(involves: 129P2/OlaHsd)
no phenotypic analysis J:154298
Abcg2tm1.1(KOMP)Vlcg/Abcg2+
(B6N(Cg)-Abcg2tm1.1(KOMP)Vlcg/J)
abnormal sleep behavior J:211773
increased total body fat amount J:211773
Abcg2tm1.1(KOMP)Vlcg/Abcg2tm1.1(KOMP)Vlcg
(B6N(Cg)-Abcg2tm1.1(KOMP)Vlcg/J)
increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Abcg2tm1.1Ssf/Abcg2tm1.1Ssf
(involves: 129 * C57BL/6 * FVB)
abnormal bone marrow cell morphology/development J:201884
abnormal endoplasmic reticulum morphology J:201884
abnormal glucose homeostasis J:201884
abnormal hepatocyte morphology J:201884
abnormal mitochondrial crista morphology J:201884
abnormal mitochondrial physiology J:201884
abnormal mitochondrion morphology J:201884
abnormal oxidative phosphorylation J:201884
abnormal respiratory electron transport chain J:201884
decreased liver glycogen level J:201884
impaired glucose tolerance J:201884
increased porphyrin level J:201884
liver inflammation J:201884
oxidative stress J:201884
Abcg2tm1Ahs/Abcg2tm1Ahs
(either: (involves: 129P2/OlaHsd * FVB) or (involves: FVB))
abnormal bile color J:80519
hematopoietic system phenotype J:80519
homeostasis/metabolism phenotype J:80519
increased circulating bilirubin level J:80519
phototoxicity J:80519
porphyria J:80519
Abcg2tm1Ahs/Abcg2tm1Ahs
(FVB.129P2-Abcg2tm1Ahs/Tac)
abnormal homeostasis J:220924
increased blood uric acid level J:220924
increased urine uric acid level J:220924
Abcg2tm1Ahs/Abcg2tm1Ahs
Tg(Thy1-AppDutch)#Jckr/0

(FVB.Cg-Abcg2tm1Ahs Tg(Thy1-AppDutch)#Jckr)
amyloid beta deposits J:178230
Abcg2tm1Ahs/Abcg2tm1Ahs
Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr/0

(FVB.Cg-Abcg2tm1Ahs Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr)
amyloid beta deposits J:178230
Abcg2tm1Bsor/Abcg2tm1Bsor
(involves: 129P2/OlaHsd * C57BL/6)
abnormal hematopoietic system morphology/development J:98134
increased physiological sensitivity to xenobiotic J:98134
Abcg2tm3.1(cre/ERT2)Bsor/Abcg2+
(involves: 129 * C57BL/6J)
no abnormal phenotype detected J:189206
Abcg4tm1Dgen/Abcg4tm1Dgen
(Not Specified)
abnormal lipid level J:141549
Abcg5tm1.1Hobb/Abcg5tm1.1Hobb
Abcg8tm1.1Hobb/Abcg8tm1.1Hobb
Speer6-ps1Tg(Alb-cre)21Mgn/?

(involves: C57BL/6 * DBA * SJL)
abnormal cellular cholesterol metabolism J:215443
abnormal feces composition J:215443
abnormal intestinal cholesterol absorption J:215443
abnormal phytosterol level J:215443
decreased cholesterol efflux J:215443
decreased circulating cholesterol level J:215443
decreased phytosterol level J:215443
increased cholesterol level J:215443
increased circulating phytosterol level J:215443
Abcg5tm1.1Hobb/Abcg5tm1.1Hobb
Abcg8tm1.1Hobb/Abcg8tm1.1Hobb
Tg(CAG-cre/Esr1*)5Amc/?

(involves: C57BL/6 * CBA * SJL)
abnormal cellular cholesterol metabolism J:215443
abnormal feces composition J:215443
abnormal intestinal cholesterol absorption J:215443
abnormal phytosterol level J:215443
decreased cholesterol efflux J:215443
decreased cholesterol level J:215443
decreased circulating cholesterol level J:215443
decreased phytosterol level J:215443
increased circulating phytosterol level J:215443
increased phytosterol level J:215443
Abcg5tm1.1Hobb/Abcg5tm1.1Hobb
Abcg8tm1.1Hobb/Abcg8tm1.1Hobb
Tg(Vil1-cre)997Gum/?

(involves: C57BL/6 * SJL)
abnormal cellular cholesterol metabolism J:215443
abnormal feces composition J:215443
abnormal intestinal cholesterol absorption J:215443
decreased cholesterol efflux J:215443
increased circulating phytosterol level J:215443
increased phytosterol level J:215443
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal liver physiology J:87209
abnormal metabolism J:87209
abnormal phospholipid level J:87209
decreased cholesterol level J:87209
decreased circulating cholesterol level J:87209
enlarged liver J:87209
increased circulating phytosterol level J:87209
increased circulating triglyceride level J:87209
increased circulating VLDL triglyceride level J:87209
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd)
abnormal bile secretion J:112995
abnormal cholesterol homeostasis J:112995
abnormal lipid homeostasis J:112995
abnormal liver physiology J:112995
increased liver weight J:112995
Abcg5trac/Abcg5trac
(A/J-Abcg5trac)
abnormal circulating cholesterol level J:157223
abnormal circulating lipid level J:157223
abnormal erythrocyte osmotic lysis J:157223
abnormal megakaryocyte differentiation J:157223
abnormal megakaryocyte morphology J:157223
abnormal megakaryocyte progenitor cell morphology J:157223
abnormal neutrophil morphology J:157223
abnormal platelet activation J:157223
abnormal platelet alpha-granule morphology J:157223
abnormal platelet morphology J:157223
abnormal spermatogenesis J:157223
anisocytosis J:157223
cardiac fibrosis J:157223
cardiomyopathy J:157223
decreased body size J:157223
decreased hematocrit J:157223
decreased leukocyte cell number J:157223
decreased platelet aggregation J:157223
female infertility J:157223
giant platelets J:157223
hemolytic anemia J:157223
hunched posture J:157223
increased bleeding time J:157223
increased mean platelet volume J:157223
increased megakaryocyte cell number J:157223
male infertility J:157223
premature death J:157223
reticulocytosis J:157223
stomatocytosis J:157223
thrombocytopenia J:157223
Abcg8tm1Elk/Abcg8+
(involves: 129S6/SvEvTac * C57BL/6J)
abnormal hepatobiliary system physiology J:94759
decreased circulating cholesterol level J:94759
Abcg8tm1Elk/Abcg8tm1Elk
(involves: 129S6/SvEvTac * C57BL/6J)
abnormal hepatobiliary system physiology J:94759
decreased cholesterol level J:94759
decreased circulating cholesterol level J:94759
increased circulating phytosterol level J:94759
increased circulating triglyceride level J:94759
Abfp4DBA/2/Abfp4DU6i
Abfp5DU6i/Abfp5DU6i

(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:101006
Abhd2Gt(pUHachi)8025Imeg/Abhd2Gt(pUHachi)8025Imeg
(involves: C57BL/6NCrj * CBA/JNCrj)
abnormal cell migration J:96209
abnormal vascular wound healing J:96209
Abhd5tm1.1Lqyu/Abhd5tm1.1Lqyu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA)
abnormal hepatocyte morphology J:199570
abnormal lipid level J:199570
abnormal liver morphology J:199570
abnormal liver physiology J:199570
abnormal phospholipid level J:199570
decreased fatty acid oxidation J:199570
decreased triglyceride lipase activity J:199570
enlarged liver J:199570
hepatic steatosis J:199570
homeostasis/metabolism phenotype J:199570
increased circulating alanine transaminase level J:199570
increased circulating aspartate transaminase level J:199570
increased liver cholesterol level J:199570
increased liver free fatty acids level J:199570
increased liver triglyceride level J:199570
increased liver weight J:199570
liver fibrosis J:199570
liver inflammation J:199570
oxidative stress J:199570
pale liver J:199570
Abhd5tm1.1Rze/Abhd5tm1.1Rze
(involves: 129P2/OlaHsd * C57BL/6)
abnormal granulocyte morphology J:160725
abnormal keratinocyte differentiation J:160725
abnormal lipid homeostasis J:160725
abnormal lipid level J:160725
abnormal skin development J:160725
abnormal skin physiology J:160725
decreased birth body size J:160725
decreased birth weight